The fetal fibronectin test: 25 years after its development, what is the evidence regarding its clinical utility? A systematic review and meta-analysis

References

• Sarri G, Davies M, Gholitabar M, et al. Guideline Development Group. Preterm labour: summary of NICE guidance. BMJ. 2015;351:h6283.
   Google Scholar
• Lackritz EM, Wilson CB, Guttmacher AE, et al. A solution pathway for preterm birth: accelerating a priority research agenda. Lancet Glob Health. 2013;1(6):e328–e330.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
   PubMed Web of Science ®Google Scholar
• Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol. 1991;138(3):537–543.
   PubMed Web of Science ®Google Scholar
• Matsuura H, Hakomori S. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA. 1985;82(19):6517–6521.
   PubMed Web of Science ®Google Scholar
• Matsuura H, Takio K, Titani K, et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem. 1988;263(7):3314–3322.
   PubMed Web of Science ®Google Scholar
• Feinberg RF, Wang CL. Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: a caveat for cervicovaginal oncofetal fibronectin testing? Am J Obstet Gynecol. 1994;171(5):1302–1308.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325(10):669–674.
   PubMed Web of Science ®Google Scholar
• Benoist G. Prédiction de l’accouchement prématuré chez les femmes symptomatiques (en situation de menace d’accouchement prématuré) [Prediction of preterm delivery in symptomatic women (preterm labor)]. J Gynecol Obstet Biol Reprod. 2016;45(10):1346–1363 [French].
   PubMedGoogle Scholar
• Berghella V, Hayes E, Visintine J, et al. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008;4(4):CD006843:CD006843.
   Google Scholar
• Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2016;215(4):431–438.
   PubMed Web of Science ®Google Scholar
• Blanc J, Bretelle F. Outils prédictifs de l’accouchement prématuré dans une population asymptomatique à haut-risque [Predictive tools of preterm birth in asymptomatic high-risk pregnancy]. J Gynecol Obstet Biol Reprod. 2016;45(10):1261–1279 [French].
   PubMedGoogle Scholar
• Chandiramani M, Di Renzo GC, Gottschalk E, et al. Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective. J Matern Fetal Neonatal Med. 2011;24(2):330–336.
   PubMed Web of Science ®Google Scholar
• Chandiramani M, Shennan A. Preterm labour: update on prediction and prevention strategies. Curr Opin Obstet Gynecol. 2006;18(6):618–624.
   PubMed Web of Science ®Google Scholar
• Chien PF, Khan KS, Ogston S, et al. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol. 1997;104(4):436–444.
   PubMedGoogle Scholar
• Compan C, Rossi A, Piquier-Perret G, et al. Prédiction de la prématurité en cas de menace d’accouchement prématuré: revue de la littérature [Prediction of spontaneous preterm birth in symptomatic patients: a review]. J Gynécol Obstét Biol Reprod. 2015;44(8):740–751 [French].
   PubMedGoogle Scholar
• Conde-Agudelo A, Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2010;23(12):1365–1376.
   PubMed Web of Science ®Google Scholar
• Daskalakis GJ, Papantoniou NE, Koutsodimas NB, et al. Fetal fibronectin as a predictor of preterm birth. J Obstet Gynaecol. 2000;20(4):347–353.
   PubMedGoogle Scholar
• Decimoni TC, Sansone D, Etto H, et al. Systematic literature review and cost-effectiveness analysis of fetal fibronectin test for predicting preterm in Brazil. Value Health. 2013;16(7): A333–AA334.
   Web of Science ®Google Scholar
• DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol. 2013;208(3):233.e1–233.e6.
   Web of Science ®Google Scholar
• Deshpande SN, van Asselt ADI, Tomini F, et al. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. Health Technol Assess. 2013;17(40):1–138.
   Web of Science ®Google Scholar
• Dos Santos F, Daru J, Rogozińska E, et al. Accuracy of fetal fibronectin for assessing preterm birth risk in asymptomatic pregnant women: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(6):657–667.
   PubMed Web of Science ®Google Scholar
• ECRI. (Organization) Health Technology Assessment Information Service. Fetal fibronectin assay for prediction of preterm birth and neonatal morbidity. Plymouth Meeting, PA: European Commission Against Racism and Intolerance. p. c2000.
   Google Scholar
• Faron G, Boulvain M, Irion O, et al. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol. 1998;92(1):153–158.
   PubMed Web of Science ®Google Scholar
• Foster C, Shennan AH. Fetal fibronectin as a biomarker of preterm labor: a review of the literature and advances in its clinical use. Biomark Med. 2014;8(4):471–484.
   PubMed Web of Science ®Google Scholar
• Hezelgrave NL, Shennan AH. Quantitative fetal fibronectin to predict spontaneous preterm birth: a review. Womens Health. 2016;12(1):121–128.
   Web of Science ®Google Scholar
• Honest H, Bachmann LM, Gupta JK, et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ. 2002;325(7359):301.
   PubMed Web of Science ®Google Scholar
• Kiefer DG, Vintzileos AM. The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth. Rev Obstet Gynecol. 2008;1(3):106–112.
   PubMedGoogle Scholar
• Leitich H, Egarter C, Kaider A, et al. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180(5):1169–1176.
   PubMed Web of Science ®Google Scholar
• Leitich H, Kaider A. Fetal fibronectin – how useful is it in the prediction of preterm birth? BJOG. 2003;110(Suppl 20):66–70.
   PubMed Web of Science ®Google Scholar
• Lucaroni F, Morciano L, Rizzo G, et al.. Biomarkers for predicting spontaneous preterm birth: an umbrella systematic review. J Matern Fetal Neonatal Med. 2018;31(6):726–734.
   PubMed Web of Science ®Google Scholar
• Medical Services Advisory Committee (MSAC). Fetal fibronectin test for predicting preterm labor (assessment report). 2007. p. 1–142. Available from: http://www.ag.gov.au/cca.
   Google Scholar
• Revah A, Hannah ME, Sue-A-Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol. 1998;15(11):613–621.
   PubMed Web of Science ®Google Scholar
• Roelens K, Roberfroid D, Ahmadzai N, et al. Prévention de l’accouchement prématuré chez les femmes à risque – evaluation de quelques mesures courantes –résumé [Prevention of preterm birth in women at risk: selected topics]. In: Good clinical practice (GCP). Bruxelles: Centre Fédéral d’Expertise des Soins de Santé (KCE); 2014. p. 1–40; KCE reports 228Bs:D/2014/10.273/xx [French].
   Google Scholar
• Ruma MS, Bittner KC, Soh CB. Current perspectives on the use of fetal fibronectin testing in preterm labor diagnosis and management. Am J Manag Care. 2017;23(19 Suppl):S356–S362.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos L, Delke I, Zamora J, et al. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol. 2009;114(3):631–640.
   PubMed Web of Science ®Google Scholar
• Son M, Miller ES. Predicting preterm birth: cervical length and fetal fibronectin. Semin Perinatol. 2017;41(8):445–451.
   PubMed Web of Science ®Google Scholar
• Smith V, Devane D, Begley CM, et al. A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol. 2007;133(2):134–142.
   PubMed Web of Science ®Google Scholar
• Vis JY, Wilms FF, Oudijk MA, et al. Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designs. Am J Perinatol. 2011;28(2):145–150.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R. Cervical phosphorylated insulin-like growth factor binding protein-1 test for the prediction of preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(1):57–73.
   PubMed Web of Science ®Google Scholar
• Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–1135.
   PubMed Web of Science ®Google Scholar
• Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Mak. 1993;13(4):313–321.
   PubMed Web of Science ®Google Scholar
• Sankey S, Weissfeld L, Fine M, et al. An assessment of the use of the continuity correction for sparse data in meta-analysis. Comm Stat Simul Comp. 1996;25(4):1031–1056. DOI:10.1080/03610919608813357.
   Web of Science ®Google Scholar
• Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351–1375.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(A):139–145.
   PubMed Web of Science ®Google Scholar
• Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323(7305):157–162.
   PubMed Web of Science ®Google Scholar
• Doebler P, Holling H. Meta-analysis of diagnostic accuracy with mada. Available from: http://cran.gis-lab.info/web/packages/mada/vignettes/mada.pdf. In: R package version 3.2.2; 2016.
   Google Scholar
• Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703–707.
   PubMed Web of Science ®Google Scholar
• Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med. 2002;21(11):1525–1537.
   PubMed Web of Science ®Google Scholar
• Holling H, Böhning W, Böhning D. Meta-analysis of diagnostic studies based upon SROC-Curves: a mixed model approach using the Lehmann family. Stat Model. 2012;12(4):347–375.
   Web of Science ®Google Scholar
• Le CT. A solution for the most basic optimization problem associated with an ROC curve. Stat Methods Med Res. 2006;15(6):571–584.
   PubMed Web of Science ®Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–990.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
   PubMed Web of Science ®Google Scholar
• Jin ZC, Zhou XH, He J. Statistical methods for dealing with publication bias in meta-analysis. Stat Med. 2015;34(2):343–360.
   PubMed Web of Science ®Google Scholar
• Abbott D, Mapara R, Sinha P, et al. Quantifiable fetal fibronectin (FFN) using 10q to accurately predict preterm birth in twin pregnancies. Twin Res Hum Genet. 2012;15(2):170–261.
   Google Scholar
• Abbott D, Radford S, Seed P, et al. The first report of a quantitative fetal fibronectin bedside analyser in the prediction of preterm birth in symptomatic women. Br J Obstet Gynaecol. 2012;119(6): e1–ee2.
   Google Scholar
• Abbott D, Radford S, Seed P, et al. The use of fetal fibronectin at 18 to 22 weeks in the prediction of preterm birth in asymptomatic women. Br J Obstet Gynaecol. 2012;119:6:e2.
   Google Scholar
• Abbott D, Smout E, Foster C, et al. The development and validation of a prediction tool for spontaneous preterm birth incorporating fetal fibronectin and cervical length. Br J Obstet Gynaecol. 2012;119:6:e1.
   Google Scholar
• Abbott D, Chandiramani M, Seed P, et al. Quantification of fetal fibronectin improves the accuracy of prediction of spontaneous preterm birth in high risk asymptomatic women. Reprod Sci. 2013;20(3 Suppl 1):124A.
   Google Scholar
• Abbott D, Radford S, Foster C, et al. Longitudinal trend of quantitative fetal fibronectin in the prediction of delivery following insertion of a rescue cerclage. J Obstet Gynaecol. 2013;33(4):414–415.
   PubMedGoogle Scholar
• Abbott D, Hezelgrave N, Seed P, et al. Equipp: Evaluation of fetal fibronectin with a novel bedside quantitative instrument for the prediction of preterm birth. J Matern Fetal Neonatal Med. 2014;27(Suppl 1):368–371.
   PubMed Web of Science ®Google Scholar
• Abbott DS, Chandiramani M, Seed PT, et al. Use of quantitative fetal fibronectin for prediction of spontaneous preterm birth in high risk asymptomatic women. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1):A56.
   Google Scholar
• Abbott DS, Hezelgrave NL, Seed PT, et al. EQUIPP: evaluation of fetal fibronectin with a novel bedside quantitative instrument for the prediction of preterm birth. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A150–AA151.
   Google Scholar
• ACOG committee opinion. Fetal fibronectin preterm labor risk test. Int J Gynecol Obstet. 1997. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists;59:164;187(September).
   Google Scholar
• Ahner R, Kiss H, Egarter C, et al. Fetal fibronectin as a marker to predict the onset of term labor and delivery. Am J Obstet Gynecol. 1995;172(1 Pt 1):134–137.
   PubMed Web of Science ®Google Scholar
• Amabebe E, Stern V, Chapman D, et al. The mid-gestational changes in cervicovaginal rantes and IL-1(beta) correlate with fetal fibronectin in asymptomatic pregnant women are predictive markers of inflammation-associated preterm birth. Reprod Sci. 2017;24(1 Suppl 1):108A–109A.
   Google Scholar
• Amabebe E, Chapman DR, Stern VL, et al. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth. J Reprod Immunol. 2018;126:1–10.
   Google Scholar
• Amabebe E, Stern V, Chapman D, et al. Predictive markers of inflammation-associated preterm birth in asymptomatic pregnant women: correlation of mid-gestational changes in cervicovaginal RANTES and IL-1(beta) with fetal fibronectin. Br J Obstet Gynaecol. 2017;124(Suppl 2):126–127.
   Google Scholar
• Amodeo Hernandez M, De La Hoz Freitas E. Preterm birth risk on multiple gestation: value of the transvaginal ultrasound cervical length measurement and the fetal fibronectin test. J Matern Fetal Neonatal Med. 2010;23(Suppl 1):307.
   Google Scholar
• Andersen HF. Use of fetal fibronectin in women at risk for preterm delivery. Clin Obstet Gynaecol. 2000;43(4):746–758.
   Google Scholar
• Ando K, Kanayama N, Terao T. The role of fibronectin in repairing fetal membrane. Nihon Sanka Fujinka Gakkai Zasshi. 1992;44(12):1564–1570. Japanese.
   PubMedGoogle Scholar
• Andrews WW, Goldenberg RL, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned from an antibiotic trial in fetal fibronectin positive women. Semin Perinatol. 2003;27(3):231–238.
   PubMed Web of Science ®Google Scholar
• Andrews WW, Sibai BM, Thom EA, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003;101(5 Pt 1):847–855.
   PubMed Web of Science ®Google Scholar
• Anonymous. Fetal fibronectin does not affect outcomes of preterm labor. J Fam Pract. 2004;53(6):442.
   PubMedGoogle Scholar
• Asakura H, Fukami T, Kurashina R, et al. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin. Gynecol Obstet Invest. 2009;68(1):1–8.
   PubMed Web of Science ®Google Scholar
• Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv. 1997;52(4 Suppl):S1–S12.
   PubMedGoogle Scholar
• Awe A, Watkins K. Fetal fibronectin: review of results at the Royal Cornwall Hospital Treliske. Br J Obstet Gynaecol. 2015;122(Suppl 2):158–159.
   Google Scholar
• Aye C, Dominey H, Shaw V, et al. Evaluating the set-up of a dedicated preterm birth clinic in a district general hospital-our 1 year experience. Br J Obstet Gynaecol. 2017;124(Suppl 2):148–149.
   Google Scholar
• Ayodele A, Fox NS, Gupta S, et al. The association between fetal fibronectin, cervical length, and amniotic fluid sludge with histological indicators of placental inflammation in twin gestations. Am J Perinatol. 2018;35(3):242–246.
   PubMed Web of Science ®Google Scholar
• Ayubi H, Abbott D, Shennan AH. Sexual intercourse increases the likelihood of a false positive fetal fibronectin test. Arch Dis Child Fetal Neonat Ed. 2012;97(Suppl 1):A108.3–A1A108.
   Google Scholar
• Bahado-Singh RO, Argoti P, Wilson L, et al. Simultaneous evaluation of epidemiologic, psychosocial, biochemical and sonographic markers for prediction of spontaneous preterm birth. Reprod Sci. 2010;17(3 Suppl 1):277A.
   Web of Science ®Google Scholar
• Bakker B. Fetal fibronectin and its clinical importance. GynakolGeburtshilfliche Rundsch. 1993;33(Suppl 1):190.
   Google Scholar
• Bare T, Manoku N. Fetal fibronectin and cericometry in patients at increased risk for premature birth. Acta Microbiol Hellen. 2015;60(3):186.
   Google Scholar
• Bare T, Mitre A, Shahinaj R, et al. Fetal fibronectin and cervicometry in patients at increased risk for premature birth [abstract]. J Perinat Med. 2015;43:S1.
   Google Scholar
• Barner JC, Petrilla AA, Kang HA, et al. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth. Am J Manag Care. 2017;23(19 Suppl):S363–S370.
   PubMed Web of Science ®Google Scholar
• Basak S, Babbur V. Audit of in-utero transfers following introduction of rapid fetal fibronectin test for assessment of preterm labor in a district general hospital in United Kingdom nº O087. [abstract]. Int J Gynecol Obstet. 2012;119(3 Suppl):S291.
   Google Scholar
• Bastek JA, Hirshberg A, Chandrasekaran S, et al. Biomarkers and cervical length to predict spontaneous preterm birth in asymptomatic high-risk women. Obstet Gynecol. 2013;122(2 Pt 1):283–289.
   PubMed Web of Science ®Google Scholar
• Bastek JA, Hirshberg A, Chandrasekaran S, et al. Do biomarkers aid cervical length in the prediction of preterm birth in asymptomatic, high risk women? Reprod Sci. 2013;20(3(Suppl 1)):235A.
   Google Scholar
• Belisle E, Gawade P, Knee A, et al. Do pregnancies complicated by preterm births with a negative fetal fibronectin screen have different characteristics compared to those that have positive fibronectin results. Am J Obstet Gynecol. 2011;204(1):S190.
   Google Scholar
• Ben-Haroush A, Poran E, Yogev Y, et al. Vaginal fetal fibronectin evaluation before and immediately after sonographic vaginal cervical length measurements in symptomatic women at risk of preterm birth: a pilot study. J Matern Fetal Neonat Med. 2010;23:854–856.
   Google Scholar
• Bergh E, Rebarber A, Oppal S, et al. The association between maternal biomarkers and pathways to preterm birth in twin pregnancies. J Matern Fetal Neonatal Med. 2015;28(5):504–508.
   PubMed Web of Science ®Google Scholar
• Bernhardt J, Dorman K. Pre-term birth risk assessment tools. Exploring fetal fibronectin and cervical length for validating risk. AWHONN Lifelines. 2004;8(1):38–44.
   PubMedGoogle Scholar
• Blackwell S, Shen X, Petrilla AA, et al. Utilization of fetal fibronectin testing and timing of delivery among emergency department admissions with symptoms of preterm labor. Am J Obstet Gynecol. 2017;216(1(Suppl 1)):S241.
   Web of Science ®Google Scholar
• Blackwell SC, Sullivan EM, Petrilla AA, et al. Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor. Clinicoecon Outcomes Res. 2017;9:585–594.
   Google Scholar
• Bolt L, Chandiramani M, De Greeff A, et al. Does fetal fibronectin testing change patient management in women at risk of pre-term labour? Int J Gynecol Obstet. 2009;107(Suppl 2):S527–S528.
   Google Scholar
• Bolt L, Chandiramani M, De Greeff A, et al. The combined use of two powerful predictors of preterm birth in high-risk asymptomatic women. Int J Gynecol Obstet. 2009;107(Suppl 2):S130–SS131.
   PubMed Web of Science ®Google Scholar
• Bolt LA, Chandiramani M, De Greeff A, et al. Combining cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high risk women. Br J Obstet Gynaecol. 2010;117:5(624).
   Google Scholar
• Bolt LA, Chandiramani M, De Greeff A, et al. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women. J Matern Fetal Neonatal Med. 2011;24(7):928–932.
   PubMed Web of Science ®Google Scholar
• Bolt LA, Morrison K, Shennan AH. The use of fetal fibronectin testing and cervical length measurement in the prediction of delivery of triplet pregnancies. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):236–237.
   PubMed Web of Science ®Google Scholar
• Bon C, Roubille M, Mailliavin A, et al. La détection de la fibronectin foetale dans l’évaluation du risque d’accouchement prématuré [Fetal fibronectin detection for prediction of preterm delivery]. Immunoanal Biol Spec. 2000;15:96–108 [French].
   Google Scholar
• Boots AB, Sanchez-Ramos L, Bowers DM, et al. The short-term prediction of preterm birth: a systematic review and diagnosis meta-analysis. Am J Obstet Gynecol. 2014;210(1):54.e1–54.e10.
   Web of Science ®Google Scholar
• Boyd KA, Briggs AH, Fenwick E, et al. Power and sample size for cost-effectiveness analysis: fFn neonatal screening. Contemp Clin Trials. 2011;32(6):893–901.
   PubMed Web of Science ®Google Scholar
• Browne H, Jassel I, Dhanji A, et al. Use of quantitative fetal fibronectin may improve risk assessment in symptomatic women at risk of preterm birth. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1):(A61).
   Google Scholar
• Brubaker SG, Gyamfi C. Prediction and prevention of spontaneous preterm birth in twin gestations. Semin Perinatol. 2012;36(3):190–194.
   PubMed Web of Science ®Google Scholar
• Bruijn MM, van Baaren G-J, Vis J, et al. Does quantitative fetal fibronectin testing improve the prediction of spontaneous preterm delivery as compared to qualitative fetal fibronectin testing in symptomatic women: a post hoc analysis [abstract]. Am J Obstet Gynecol. 2014;210:S364.
   Google Scholar
• Bruijn M, Van Baaren G-J, Vis J, et al. Comparison of the Actim Partus test and fetal fibronectin test in combination with cervical length in the prediction of spontaneous preterm delivery in symptomatic women: a post-hoc analysis. Am J Obstet Gynecol. 2014;210(1(Suppl 1)):S363–SS364.
   PubMed Web of Science ®Google Scholar
• Bruijn MM, Kamphuis E, Hoesli I, et al. Does quantitative fetal fibronectin testing add to cervical length measurement and qualitative fetal fibronectin testing; (I) Identification of low risk women with threatened preterm labor (EUFIS study) [abstract]. Am J Obstet Gynecol. 2015;212(1):S190–S191.
   Web of Science ®Google Scholar
• Bruijn M, Kamphuis E, Hoesli I, et al. Does quantitative fetal fibronectin testing add to cervical length measurement and qualitative fetal fibronectin testing; (II) Absolute probability of preterm delivery <7 days in women with threatened preterm labor (EUFIS study). Am J Obstet Gynecol. 2015;212(1 Suppl 1):S191–SS192.
   PubMed Web of Science ®Google Scholar
• Bruijn MM, Vis JY, Wilms FF, et al. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women. BJOG. 2016;123(12):1965–1971.
   PubMed Web of Science ®Google Scholar
• Bruijn MM, Hermans FJ, Vis JY, et al. Which factors contribute to false-positive, false-negative, and invalid results in fetal fibronectin testing in women with symptoms of preterm labor? Am J Perinatol. 2017; 34(3):234–239.
   PubMed Web of Science ®Google Scholar
• Bruijn MM, Vis JY, Wilms FF, et al. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement. Eur J Obstet Gynecol Reprod Biol. 2016;206:220–224.
   Google Scholar
• Byrne J, Govindaswami B, Jegatheesan P, et al. Perinatal core measure: antenatal steroid performance improvement following a preterm birth risk assessment decision model and perinatal QI toolkit. Am J Obstet Gynecol. 2011;204(1):S193.
   PubMed Web of Science ®Google Scholar
• Calvert B, Hezelgrave N, Seed P, et al. PFM.07  Quantitative fetal fibronectin testing as a predictor of spontaneous preterm delivery after cervical surgery. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A84.3–A8A84.
   Google Scholar
• Carter J, Hezelgrave N, Seed P, et al. Combined fetal fibronectin and saliva progesterone measurement for prediction of spontaneous preterm birth. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A12.
   Google Scholar
• Carter J, Hezelgrave NL, Seed PT, et al. Combined fetal fibronectin and saliva progesterone measurement for prediction of spontaneous preterm birth. Reprod Sci. 2014;21:3:Suppl 1:150A–151A.
   Web of Science ®Google Scholar
• Chan RL. Biochemical markers of spontaneous preterm birth in asymptomatic women. BioMed Res Int. 2014;2014:164081.
   Google Scholar
• Chandiramani M, Kurtzman J, Briley A, et al. Fetal fibronectin levels at 24 weeks are predictive of recurrent PPROM and subsequent spontaneous preterm delivery (SPTD) in asymptomatic patients with a history of PPROM [abstract]. Am J Obstet Gynecol. 2009;20:S177.
   Google Scholar
• Chandiramani M, De Greeff A, Filmer J, et al. The availability of fetal fibronectin for the management of asymptomatic high-risk women in a preterm surveillance clinic: effect on utilisation of hospital resources. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa123.
   Google Scholar
• Chandiramani M, Seed P, Shennan AH, et al. Association between cervicovaginal cytokines and fetal fibronectin in women at risk of spontaneous preterm labour. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa123–Fa124.
   Google Scholar
• Chandiramani M, De Greeff A, Filmer J, et al. The affirm study: assessment of fetal fibronectin testing to improve preterm management. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1) Fa65–Fa66.
   Google Scholar
• Chandiramani M, Das A, Bolt LA, et al. Assessment of fetal fibronectin testing to improve preterm birth management. Reprod Sci. 2014;21(3 Suppl 1):151A–152A.
   Web of Science ®Google Scholar
• Chen C-Y, Chang C-C, Yu C, et al. Immunomagnetic reduction for fetal fibronectin detection a novel method to detect the preterm biomarker. Biomed Eng Appl Basis Commun. 2011;23(4):273–278.
   Web of Science ®Google Scholar
• Chen C-Y, Chang C-C, et al. Clinical application of surface plasmon resonance-based biosensors for fetal fibronectin detection. Sensors. 2012;12(4):3879–3890.
   PubMed Web of Science ®Google Scholar
• Chigusa Y, Mogami H, Kishore AH, et al. Key determinants of fetal fibronectin extra domain-a (EDA)-induced activation of TLR4. Reprod Sci. 2015;22(Suppl 1):67A.
   Google Scholar
• Chimura T, Hirayama T, Oda T, et al. Clinical evaluation of flomoxef in the treatment of chorioamnionitis and changes in the fetal fibronectin level in vaginal secretion. Jpn J Antibiot. 1993;46(2):164–170 [Japanese ].
   PubMedGoogle Scholar
• Chuck AW, Thanh NX, Chari RS, et al. Post-policy implementation review of rapid fetal fibronectin (fFN) testing for preterm labor in Alberta. J Obstet Gynaecol Can. 2016;38(7):659–666.e6.
   PubMed Web of Science ®Google Scholar
• Combs CA, Garite T, Maurel K, et al. Fetal fibronectin and cervical length as predictors of preterm birth in twin pregnancies, with or without 17-hydroxyprogesterone caproate. Am J Obstet Gynecol. 2013;208(1 Suppl 1):S205.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R. Fetal fibronectin as a predictor of spontaneous preterm delivery in multiple gestations: a systematic review and meta-analysis [abstract]. Am J Obstet Gynecol. 2009;201:S196.
   Google Scholar
• Conde-Agudelo A, Romero R. Prediction of preterm birth in twin gestations using biophysical and biochemical tests. Am J Obstet Gynecol. 2014;211(6):583–595.
   PubMed Web of Science ®Google Scholar
• Crane J, Armson BA, Dodds L, et al. Predicators of preterm delivery [abstract]. Am J Obstet Gynecol. 1998;178:S189.
   Google Scholar
• Dawes L, Miller L, Subramoney M. The Impact on Education and audit on compliance with a clinical guideline for fetal fibronectin testing and the management of threatened preterm labour at National Women’s Health, Auckland City Hospital. Br J Obstet Gynaecol. 2015;122( Suppl 2):237.
   Google Scholar
• Dawes LK, Subramoney M, Miller LM, et al. Increasing compliance with a clinical practice guideline for fetal fibronectin testing and the management of threatened preterm labour: a quality improvement project. Eur J Obstet Gynecol Reprod Biol. 2018;221:89–96.
   Google Scholar
• Diaz-Cueto L, Dominguez-Lopez P, Tena-Alavez G, et al. Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test. Int J Gynecol Obstet. 2009;107(2):143–146.
   PubMed Web of Science ®Google Scholar
• Driul L, Cacciaguerra G, Calcagno A, et al. Pretern delivery predation: use of fetal fibronectin in comparison and association with ultrasound measurement of cervical length and clinically evaluated cervical dilatation. Ital J Gynaecol Obstet. 2009;21(2): 81–85. Italian.
   Google Scholar
• Dudley D. Serial transvaginal cervical length measurements and quantitative vaginal fetal fibronectin concentrations did not predict spontaneous preterm birth in low-risk nulliparous women. Evid Based Med. 2017;22(5):188.
   PubMedGoogle Scholar
• Dutta D, Norman JE. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labor. J Obstet Gynaecol. 2010;30(8):768–773.
   PubMedGoogle Scholar
• Elliott JP, Miller HS, Coleman S, et al. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin. J Perinatol. 2005;25(10):626–630.
   PubMedGoogle Scholar
• Eriksen NL, Parisi VM, Daoust S, et al. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol. 1992;80(3 Pt 1):451–454.
   PubMed Web of Science ®Google Scholar
• Esplin M. The use of serial cervical length and quantitative fetal fibronectin to identify nulliparous women at risk of subsequent spontaneous preterm birth [abstract]. Am J Obstet Gynecol. 2016;214(1):S4–S5.
   Web of Science ®Google Scholar
• Esplin MS, Elovitz MA, Iams JD, et al. Predictive accuracy of serial transvaginal cervical lengths and quantitative vaginal fetal fibronectin levels for spontaneous preterm birth among nulliparous women. JAMA: J Am Med Assoc. 2017;14(317 (10)):1047–1056.
   Web of Science ®Google Scholar
• Evantash E. Vaginal fetal fibronectin to predict spontaneous preterm birth. JAMA. 2017;318(2):198–199.
   PubMed Web of Science ®Google Scholar
• Feinberg RF, Kliman HJ. Fetal fibronectin and preterm labor [letter]. N Engl J Med. 1992;326:708. author reply:709.
   Google Scholar
• Fields N, Van Winden T, Mol B. Implementation of fetal fibronectin testing for threatened pre-term labor: a retrospective cohort from the Australian tertiary centre perspective. Aust N Z J Obstet Gynaecol. 2017;57(Suppl 1):42.
   Google Scholar
• Fell DB, Sprague AE, Grimshaw AS, et al. Evaluation of the impact of fetal fibronectin test implementation on hospital admissions for preterm labor in Ontario: a multiple baseline time-series design. Br J Obstet Gynaecol. 2014;121:438–446.
   Google Scholar
• Fiorini F, Isted A, Hezelgrave NL, et al. Quantitative fetal fibronectin predicts preterm birth in women with bulging fetal membranes. Eur J Obstet Gynecol Reprod Biol. 2016;203:127–131.
   Google Scholar
• Foong E, Chye Chuah S. Clinical application of quantitative fetal fibronectin testing in the management of preterm labour at a Regional Hospital. Aust N Z J Obstet Gynaecol. 2016;56(Suppl 1):37–38.
   Google Scholar
• Fox NS, Saltzman DH, Klauser CK, et al. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol. 2009;201(3):313.e1–313.e5.
   Web of Science ®Google Scholar
• Fox NS, Saltzman DH, Roman A, et al. Prediction of spontaneous preterm birth in asymptomatic triplet pregnancies using combined fetal fibronectin and cervical length [abstract]. Am J Obstet Gynecol. 2012;206:S233.
   Google Scholar
• Fox NS, Saltzman DH, Fishman A, et al. Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins. J Ultrasound Med. 2015;34(6):977–984.
   PubMed Web of Science ®Google Scholar
• Fox NS, Spiegelman J, Booker W, et al. The independent association of a short cervix, positive fetal fibronectin, cervical sludge, and cervical funneling with preterm birth in twin pregnancies [abstract]. Am J Obstet Gynecol. 2016;214:S360.
   Google Scholar
• French L. Fetal fibronectin to predict preterm delivery. J Fam Pract. 1998;47(4):250–251.
   PubMedGoogle Scholar
• Fricke E. A quality analysis of the evaluation of preterm labor. Am J Obstet Gynecol. 2015;212(1 Suppl 1):S66.
   Web of Science ®Google Scholar
• Frost N. Introduction of fetal fibronectin in a tertiary obstetric unit. J Matern Fetal Neonatal Med. 2014;27(Suppl 1):364.
   Google Scholar
• Gaikwad VA, Rajput UG, Puri MS. Cervicovaginal fluid fibronectin level in assessing risk of preterm labour. Res J Pharm Biol Chem Sci. 2014;5:156–162.
   Google Scholar
• Gardner M, Rouse D, Joffe G. Cost–benefit analysis of fetal fibronectin screening [abstract]. Am J Obstet Gynecol. 1998;178:S121.
   Google Scholar
• Garite TJ, Lockwood CJ. A new test for diagnosis and prediction of preterm delivery; Jan. Ob: Contemporary Book Company/Gyn 1996. p. 77–84.
   Google Scholar
• Garite T, Lucah LC, Williams C, et al. A comparison of speculum and non-speculum collection of cervicovaginal swab specimens for fetal fibronectin testing [abstract]. Am J Obstet Gynecol. 2005;193:S52.
   Google Scholar
• Gaucherand P, Guibaud S, Forestier AV, et al. La fibronectin: nouveau marqueur de la menace d’accouchement prématuré. Jobgyn. 1995;3:17–20 [French].
   Google Scholar
• Gebhardt S, Odendaal HJ. Fetal fibronectin in vaginal secretions –a predictor of preterm delivery ? [letter]. S Afr Med J. 1995;85(3):188.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Marsoni V, Reveane A, et al. Fetal fibronectin: the relevance of repeated testing in the prediction of preterm delivery [abstract]. Proceedings of the 3rd World Congress of Perinatal Medicine; 1997, September. Roma, Italy.
   Google Scholar
• Gibson JL, Macara LM, Owen P, et al. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol. 2004;23(6):561–566.
   PubMed Web of Science ®Google Scholar
• Gibson S, Hezelgrave NL, Shennan AH. Management of vasa praevia: a potential role for cervical length and quantitative fetal fibronectin measurement. J Obstet Gynaecol. 2013;33(8):905–906.
   PubMedGoogle Scholar
• Gibson S, Hezelgrave NL, Shennan AH. PPO.04  The impact of quantitative fetal fibronectin on the clinical management of women symptomatic of preterm labour. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A151.3–A1A155.
   Google Scholar
• Goepfert AR, Andrews WW. The preterm prediction study: association between cervical interleukin-6 (IL-6), fetal fibronectin (FFN), and spontaneous perterm birth (SPTB) [abstract]. Am J Obstet Gynecol. 1997;176:S6.
   Google Scholar
• Goepfert AR, Schwebke J, Andrews WW, et al. Perinatal emphasis research center (PERC): vaginal markers of perterm birth [abstract]. Am J Obstet Gynecol. 2002;187:S126.
   Google Scholar
• Goepfert AR, Goldenberg RL, Mercer B, et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;183(6):1480–1483.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams J, Mercer B, et al. Fetal fibronectin and spontaneous preterm birth [abstract]. Am J Obstet Gynecol. 1995;172:254.
   Google Scholar
• Goldenberg RL, Iams JD, Miodovnik M, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996;175(4 Pt 1):1047–1053.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Thom E, Moawad AH, et al. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 1996;87(5 Pt 1):656–660.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Mercer BM, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health. 1998;88(2):233–238.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Das A, et al. The preterm prediction study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth [abstract]. Am J Obstet Gynecol. 2000;182:S27.
   Google Scholar
• Goldenberg RL, Das A. Fetal fibronectin and bacterial vaginosis in smokers and nonsmokers. The National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;182(1 Pt 1):164–166.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Das A, et al. The Preterm Prediction Study. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;182(3):636–643.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Klebanoff M, Carey JC, et al. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol. 2001;185(2):485–486.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Mercer BM, et al. The Preterm Prediction Study. Toward a multiple marker test for spontaneous preterm birth. Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2001;185(3):643–651.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Andrews W, Taha T, et al. HIVNET 024: fetal fibronectin (FFN), preterm birth (PTB) and mother to child transmission of HIV (MTCT) in African women with HIV [abstract]. Am J Obstet Gynecol. 2005;193:S52.
   Google Scholar
• Goldenberg RL, Andrews WW, Hoffman I, et al. Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trial. Obstet Gynecol. 2007;109(2 Pt 1):392–401. Erratum in: Obstet Gynecol. 2007;110:936.
   PubMed Web of Science ®Google Scholar
• Golic M, Siedentopf JP, Pauly F, et al. Influence of transvaginal ultrasound examination on quantitative vaginal fibronectin measurements: a prospective evaluation study.J Perinat Med. 2016;45(1):85–89. DOI:10.1515/jpm-2015-0270.
   Google Scholar
• Gomez R, Romero R, Montiel C, et al. Cervico-vaginal fetal fibronectin improves the prediction of preterm delivery estimated by sonographic cervical length in patients with preterm labor and intact membranes [abstract]. Am J Obstet Gynecol. 2002;187:S80.
   Google Scholar
• Greenhagen JB, Van Wagoner J, Dudley D, et al. The value of fetal fibronectin as a predictor of preterm delivery in low risk women [abstract]. Am J Obstet Gynecol. 1996;176(1 Suppl):471S.
   Google Scholar
• Grobman W, Welshman E, Calhoun E. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs?: a randomized trial [abstract]. Am J Obstet Gynecol. 2002;187:S80.
   Google Scholar
• Grover CM. Use of the fetal fibronectin assay to avert unnecessary hospitalization and bedrest in patients with preterm labor symptoms: a cost analysis. Prim Care Update Ob Gyns. 1998;5(4):178–179.
   Google Scholar
• Guller S, LaCroix NC, Kirkun G, et al. Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts. J Steroid Biochem Mol Biol. 1993;46(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hadži-Lega M, Daneva Markova A, Tanturovski M. Interleukin 6 and fetal fibronectin in prediction of preterm delivery in symptomatic patients. J Matern Fetal Neonatal Med. 2014;27(Suppl 1):373.
   Google Scholar
• Hadzi-Lega M, Daneva Markova A, Stefanovic M, et al. Interleukin-6 and fetal fibronectin as a predictors of preterm delivery in symptomatic patients. Bosn J Basic Med Sci. 2015;15(1):51–56.
   PubMed Web of Science ®Google Scholar
• Hadži-Lega M, Daneva Markova A, Girevski V. Correlation of cervical length and different biochemical markers in spontaneous preterm birth up to 7 days in symptomatic patients. J Perinat Med. 2015;43(Suppl 1)248.
   PubMed Web of Science ®Google Scholar
• Hadži-Legal M, Markova AD, Stefanovic M, et al. Combination of selected biochemical markers and cervical length in the prediction of impending preterm delivery in symptomatic patients. Clin Exp Obstet Gynecol. 2016;43(1):154–160.
   PubMed Web of Science ®Google Scholar
• Hampel DJ, Köttgen B, Dudenhausen JW, et al. Fetal fibronectin as a marker for an imminent (preterm) delivery. A new technique using the glycoprotein lectin immunosorbent assay. J Immunol Methods. 1999;224(1–2):31–42.
   PubMed Web of Science ®Google Scholar
• Hampl M, Friese K, Hofmann I, et al. Quantitative Bestimmung von fetalem Fibronektin im Zervicovaginalabstrich: ein Neuer Marker zur Beurteilung Des Frühgeburtsrisikos bei vorzeitiger Wehentätigkeit [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor]. Geburtshilfe Frauenheilkd. 1994;54(12):685–690.
   PubMed Web of Science ®Google Scholar
• Han YS, Ha EH, Park HS, et al. Relationships between pregnancy outcomes, biochemical markers and pre-pregnancy body mass index. Int J Obes (Lond). 2011;35(4):570–577.
   PubMed Web of Science ®Google Scholar
• Hansen W, Lowe P, Zimmerman B. Effect of the fetal fibronectin assay on preterm labor management [abstract]. Am J Obstet Gynecol. 2001;185:S136.
   Google Scholar
• Hartog M, Todesco M, Lapaire O, et al. A comparison between fetal fibronectin and sonographic cervical length measurement for estimating the risk of preterm birth in singleton and twin pregnancies. Int J Gynecol Obstet. 2009;107(Suppl 2):S199.
   Google Scholar
• Heggie R, Boyd K, Stock S, et al. How should we test for pre-term labour? An economic model and cost-effectiveness analysis. Value Health. 2017;20(9):A600.
   Web of Science ®Google Scholar
• Hendler I, Andrews WW, Carey CJ, et al. National Institute of Child Health and Human Development, maternal-Fetal Medicine Units Network. The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol. 2007;197(5):488.e1–488.e5.
   Web of Science ®Google Scholar
• Heng YJ, Pennell CE, Chua HN, et al. Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor. PLoS One. 2014;9(5):e96901.
   PubMed Web of Science ®Google Scholar
• Hepburn CM, Booth M. Fetal fibronectin testing in Ontario: successful government-sector collaboration to achieve high-quality and sustainable system change. Health. 2011;14(Spec No 3):90–94.
   Google Scholar
• Herbst A, Nilsson C. Diagnosis of early preterm labor. Br J Obstet Gynaecol. 2006;113(Suppl 3):60–67. Erratum in: Herbst A, Nilsson C. Br J Obst Gynaecol. 2008;113:674–675
   Google Scholar
• Hermans FJR, Bruijn MMC, Vis JY, et al. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days. Acta Obstet Gynecol Scand. 2015;94(7):715–721.
   PubMed Web of Science ®Google Scholar
• Hermans FJ, Schuit E, Opmeer BC, et al. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial). BMC Pregnancy Childbirth. 2016;16(1):154.
   PubMed Web of Science ®Google Scholar
• Heyborne KD. Fetal fibronectin testing in threatened preterm labor: time for more study! [letter]. Am J Obstet Gynecol. 2017;217(1):94.
   PubMed Web of Science ®Google Scholar
• Hezelgrave NL, Duckworth S, Seed P, et al. Can fetal fibronectin testing and cervical length measurement direct appropriate prophylactic steroid use in high-risk, asymptomatic women? Arch Dis Child Fetal Neonat Ed:Fa55. 2011;96(Suppl 1):Fa55–Fa55.
   Google Scholar
• Hezelgrave NL, Abbott DS, Radford SK, et al. Quantitative fibronectin can be used for earlier prediction of preterm birth from 18 weeks, but the positive threshold needs redefining. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1)A6.
   Google Scholar
• Hezelgrave NL, Seed P, Tribe RM, et al. Early fetal fibronectin testing at 18 weeks’ predicts spontaneous preterm birth, though accuracy is improved with combined CL testing. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A152.
   Google Scholar
• Hezelgrave N, Kurtzman J, Abbott D, et al. Quantitative fetal fibronectin assessment at 22 0/7-27 6/7 weeks' GA significantly modifies the risk of preterm birth in asymptomatic high risk patients with sonographic cervical shortening [abstract]. Am J Obstet Gynecol. 2015;212:S8–S9.
   Google Scholar
• Hezelgrave NL, Kuhrt K, Cottam K, et al. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth. Eur J Obstet Gynecol Reprod Biol. 2017;208:103–108.
   Google Scholar
• Hincz P, Wilczyński J, Pawłowicz P, et al. Fetal fibronectin as a predictor of preterm delivery in patients with preterm contractions and cervical changes. Ginekol Pol. 2000;71(8):728–732 [Polish].
   PubMedGoogle Scholar
• Honest H, Forbes CA, Durée KH, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2009;13(43):1–627.
   PubMed Web of Science ®Google Scholar
• Hong JS, Yoon BH, Romero R, et al. Patients with a positive cervical fetal fibronectin followed by a negative test have a reduced likelihood of spontaneous preterm delivery [abstract]. Am J Obstet Gynecol. 2003;189:S173.
   Google Scholar
• Hughes K, Sim S, Roman A, et al. Outcomes and predictive tests from a dedicated specialist clinic for women at high risk of preterm labour: a ten year audit. Aust N Z J Obstet Gynaecol. 2017;57(4):405–411.
   PubMed Web of Science ®Google Scholar
• Hulin N. Fibronectin foetale et délivrance imminente. Biol Clin. 1991;25:15–20 [French].
   Google Scholar
• Iams JD for the NICHD Maternal-Fetal Medicine Units Network. The preterm prediction study: screening low risk women for spontaneous preterm birth with digital examination, fibronectin, and sonographic cervical length [abstract]. Am J Obstet Gynecol. 1997;176:S51.
   Google Scholar
• Iams JD, Goldenberg RL, Mercer BM, et al. for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The preterm prediction study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1998;178(5):1035–1040.
   PubMed Web of Science ®Google Scholar
• Iams JD, Goldenberg RL, Mercer BM, et al. The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol. 2001;184(4):652–655.
   PubMed Web of Science ®Google Scholar
• Ichijo M. Clinical significance of oncofetal fibronectin in vaginal secretion for diagnosis of preterm delivery. San- Fujinka Chiryo. 1992;67:212–218. Japanese.
   Google Scholar
• Irion O, Matute J, Bischof P, et al. Cervical oncofetal fibronectin as a predictor of preterm delivery [abstract]. Am J Obstet Gynecol. 1996;170:384.
   Google Scholar
• Jackson GM, Edwin SS, Varner MW, et al. Regulation of fetal fibronectin production in human chorion cells. Am J Obstet Gynecol. 1993;169(6):1431–1435.
   PubMed Web of Science ®Google Scholar
• Jafee S, Razavi A, Bibbo C, et al. Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit? Am J Obstet Gynecol. 2013;208: S225–SS226.
   Google Scholar
• Jimenez G, Garcia A, Casal D, et al. Fetal fibronectin as an aid for prediction of preterm delivery [abstract]. Int J Gynecol Obstet. 1994;46(1 Suppl):145S.
   PubMed Web of Science ®Google Scholar
• Joffe G, Jacques D, Burton B, et al. Impact of fetal fibronectin assay on admissions for preterm labor [abstract]. Am J Obstet Gynecol. 1998;180:S11.
   Google Scholar
• Jones G, Poston L. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. BJOG: Int J O&G. 1998;105(2):244–245.
   Web of Science ®Google Scholar
• Jwala S, Tran TL, Terenna C, et al. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women. Acta Obstet Gynecol Scand. 2016;95(8):948–955.
   PubMed Web of Science ®Google Scholar
• Kalchbrenner M, Weisenborn B, Jacques D, et al. A randomized comparison of specimen collection methods for the fetal fibronectin immunoassay. Obstet Gynecol. 1999;93(Suppl 4):51S.
   PubMed Web of Science ®Google Scholar
• Kang JH, Lee SE, Park CW, et al. Cervical fetal fibronectin: an index of intra-amniotic inflammation, histologic chorioamnionitis and impending preterm delivery in patients with preterm labor and intact membranes [abstract]. Am J Obstet Gynecol. 2007;197:S47.
   Google Scholar
• Karamisheva V, Ivanov S, Nikolov A, et al. Identification of preterm labor: the role of fetal fibronectin in parents with symptoms. Akush Ginekol. 2014;53(S):15–19 [Bulgarian].
   PubMedGoogle Scholar
• Karamisheva V, Ivanov S, Nikolov A, et al. Identification the risk of preterm labor: the role of fetal fibronectin. Akush Ginekol. 2015;54(1):3–6. Bulgarian
   PubMedGoogle Scholar
• Kay S, McKie L, Ajoku K, et al. Fetal fibronectin testing in a district general hospital setting – are we changing our management of women with symptomatic preterm labour? Br J Obstet Gynaecol. 2015;122(Suppl 2):186.
   Google Scholar
• Keeler S, Roman A, Coletta J, et al. Fetal fibronectin testing prior to ultrasound-indicated cerclage: can it predict procedure success? [abstract]. Am J Obstet Gynecol. 2007;197:S199.
   Google Scholar
• Khambay H, Bolt L, Chandiramani M, et al. The use of phosphorylated insulin-like growth factor binding protein-1, the actim partus test to predict preterm birth in asymptomatic high risk women. Arch Dis Child Fetal Neonat Ed. 2010;95(Suppl 1):Fa92-Fa93:Fa92–Fa93.
   Google Scholar
• Khambay H, Bolt L, Chandiramani M, et al. The use of phosphorylated insulin-like growth factor binding protein-1, the actim partus test to predict preterm birth in asymptomatic high-risk women. J Matern Fetal Neonat Med. 2010;23(Suppl 1):109–110.
   Google Scholar
• Khandelwal M, Lynch L, Lockwood CJ, et al. Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester. Am J Perinatol. 1995;12(3):161–163.
   PubMed Web of Science ®Google Scholar
• Kiefer D, Keeler S, Rust O, et al. Is Fetal fibronectin (FFN) a marker of intra-amniotic inflammation in patients with midtrimester short cervix? Am J Obstet Gynecol. 2009;201:6 Suppl 1:S60–S61.
   Web of Science ®Google Scholar
• Kim RS, Gupta S, Lam-Rachlin J, et al. Fetal fibronectin, cervical length, and the risk of preterm birth in patients with an ultrasound or physical exam indicated cervical cerclage. J Matern Fetal Neonat Med. 2016;18:1–16.
   Google Scholar
• Knee A, Belisle E, Markenson G, et al. Do pregnancies complicated by preterm births with a negative fetal fibronectin screen have different characteristics compared to those that have positive fibronectin results? [abstract]. Am J Obstet Gynecol. 2011;204:S186.
   Google Scholar
• Koenn ME. Fetal fibronectin. Clin Lab Sci. 2002;15(2):96–8, 115, 96–8, 115.
   PubMedGoogle Scholar
• Kolev N, Ivanov S, Kozovski I, et al. Combined application of fetal fibronectin and insulin-like growth factor in preterm delivery diagnosis – our results. Akush Ginekol. 2015;54:8–12 [Bulgarian].
   Google Scholar
• Krupa FG, Faltin D, Cecatti JG, et al. Predictors of preterm birth. Int J Gynecol Obstet. 2006;94(1):5–11.
   PubMed Web of Science ®Google Scholar
• Kühnert M. Individual management of preterm labour by using rapid fetal fibronectin test. J Mat Fetal Neonat Med. 2014;27(Suppl 1):(392–393).
   Google Scholar
• Kuhrt K, Seed P, Smout E, et al. The development and validation of a new tool to predict spontaneous preterm birth in high-risk women using quantitative fetal fibronectin and cervical length. Br J Obstet Gynaecol. 2013;120(Suppl 1):(14–15).
   Google Scholar
• Kuhrt K, Seed P, Smout E, et al. Development and validation of a predictive tool for spontaneous preterm birth incorporating cervical length and quantitative fetal fibronectin in asymptomatic high risk women. Br J Obstet Gynaecol. 2014;121(7):e3–ee4.
   Google Scholar
• Kuhrt K, Unwin C, Hezelgrave N, et al. Endocervical and high vaginal quantitative fetal fibronectin in predicting preterm birth. Br J Obstet Gynaecol. 2014;27(7):e13.
   Google Scholar
• Kuhrt K, Smout E, Hezelgrave N, et al. Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women. Ultrasound Obstet Gynecol. 2016;47(1):104–109.
   PubMed Web of Science ®Google Scholar
• Kuhrt K, Hezelgrave N, Foster C, et al. Development and validation of a tool incorporating quantitative fetal fibronectin to predict spontaneous preterm birth in symptomatic women. Ultrasound Obstet Gynecol. 2016;47(2):210–216.
   PubMed Web of Science ®Google Scholar
• Kuin RA, Vis JY, Mol BW. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients. Obstet Gynecol. 2010; 115: 186–187; author reply 187. [letter]. author reply:7.
   Google Scholar
• Kurtzman J, Chandiramani M, Briley A, et al. Quantitative fetal fibronectin screening at 24 weeks delineates the risk of spontaneous preterm delivery in asymptomatic patients with a prior history of preterm premature rupture of membranes (PPROM) [abstract]. Am J Obstet Gynecol. 2009;201:S177.
   Google Scholar
• Kurtzman J, Chandiramani M, Briley A, et al. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery. Am J Obstet Gynecol. 2009;200(3):263.e1–263.e6.
   PubMed Web of Science ®Google Scholar
• Kurtzman J, Hezelgrave N, Abbott D, et al. Prediction of preterm birth in asymptomatic patients with twin gestations using a single quantitative fetal fibronectin screen. Am J Obstet Gynecol. 2014;210(1 Suppl 1):S387.
   PubMed Web of Science ®Google Scholar
• Kurtzman J, Hezelgrave N, Abbott D, et al. Quantitative fetal fibronectin and cervical length screening at 22–27 6/7 week’s GA illuminate the spectrum of risk of preterm birth in asymptomatic twin gestations [abstract]. Am J Obstet Gynecol. 2014;210(1):S386–S387.
   Web of Science ®Google Scholar
• Lamont RF, Dragovic B. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al. Br J Obstet Gynaecol. 2006;113:850–851; author reply:851.
   Google Scholar
• Stafford IP, Garite TJ, Dildy GA, et al. A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol. 2008;199(2):131.e1–131.e4.
   Web of Science ®Google Scholar
• Lawin-O’Brien A, Jesner O, Biswas C. PLD.44  Evaluation of fetal fibronectin testing, subsequent management and outcomes in a London Teaching Hospital. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1) :A119.2–A1A119.
   Google Scholar
• Leeson S, Maresh M. Fibronectin: a predictor of preterm delivery? [commentary]. Br J Obstet Gynaecol. 1993;100(4):304–306.
   PubMedGoogle Scholar
• Leeson S, Maresh MJ. Predicting preterm delivery: the fetal fibronectin test. Prof Care Mother Child. 1994;4(2):38–39.
   PubMedGoogle Scholar
• Leitich H. Secondary predictors of preterm labor. BJOG. 2005;112(Suppl 1):48–50.
   PubMed Web of Science ®Google Scholar
• Leitich H. Controversies in diagnosis of preterm labor. BJOG. 2005;112(Suppl 1):61–63.
   PubMed Web of Science ®Google Scholar
• Levine LD, Romero JA, Pappas H, et al. A prospective blinded cohort study evaluating fetal fibronectin and cervical length in predicting preterm birth in symptomatic women [abstract]. Am J Obstet Gynecol. 2016;214(1):S441–S442.
   Web of Science ®Google Scholar
• Li R. Application of fFn and CRP in the evaluation of therapeutic effect for preterm labor. Zhongguo Yi Liao Qi Xie Zhi. 2015;39:77–78 [Chinese].
   Google Scholar
• Lifshitz SJ, Razavi A, Bibbo C, et al. Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit? J Matern Fetal Neonatal Med. 2014;27(6):566–570.
   PubMed Web of Science ®Google Scholar
• Lin M. Impact of quantitative fetal fibronectin (FFN) change on efficacy of antibiotic vs. placebo treatment of asymptomatic fFN positive women to prevent subsequent preterm birth (PB) [abstract]. Am J Obstet Gynecol. 2005;193:S56.
   Google Scholar
• Lopez RL, Francis JA, Garite TJ, et al. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol. 2000;182(5):1103–1106.
   PubMed Web of Science ®Google Scholar
• Lu GC, Goldenberg RL, Cliver SP, et al. Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women. Obstet Gynecol. 2001;97(2):225–228.
   PubMed Web of Science ®Google Scholar
• Lukes AS, Thorp JM Jr, Eucker B, et al. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol. 1997;176(3):639–641.
   PubMed Web of Science ®Google Scholar
• Luo L, Lü Q, Wei F. Fetal fibronectin and preterm birth. Zhonghua Fu Chan Ke Zhi. 1997;32(1):25–26. Chinese.
   PubMedGoogle Scholar
• MacDonald WA, Bender M, Saxton A. Use of fetal fibronectin in the management of preterm labor in Nunavut. Alaska Med. 2007;49(2 Suppl):215–217.
   PubMedGoogle Scholar
• Macones GA. Fetal fibronectin testing in threatened preterm labor: time to stop. Am J Obstet Gynecol. 2016;215(4):405.
   PubMed Web of Science ®Google Scholar
• Mailath-Pokorny M, Polterauer S, Kohl M, et al. Individualized assessment of preterm birth risk using two modified prediction models. Eur J Obstet Gynecol Reprod Biol. 2015;186:42–48.
   Google Scholar
• Makrydimas G, Sotiriadis A. Prediction of preterm birth in twins. Best Pract Res Clin Obstet Gynaecol. 2014;28(2):265–272.
   PubMed Web of Science ®Google Scholar
• Malagrida L, Rozenberg P, Simon G, et al. Intérêt de la détection de la fibronectin foetale dans les sécrétions cervico-vaginales pour la prédiction de l’accouchement prématuré [Detection of fetal fibronectin in cervical and vaginal secretions to predict preterm birth]. Immunoanal Biol Spéc. 1995;10:355–359 [French].
   Google Scholar
• Mancuso M, Biggio J, Owen J. Fetal fibronectin and latency period in women with arrested preterm labor. Am J Obstet Gynecol. 2013;208(1 Suppl 1):S221.
   PubMed Web of Science ®Google Scholar
• Manolea MM, Dijmarescu A-L, Novac L, et al. Combined factors for predicting preterm delivery. J Perinat Med. 2013;41(Suppl 1)482.
   Google Scholar
• Mapara R, Abbott DS, Hezelgrave NL, et al. The role of quantitative fetal fibronectin and cervical length in predicting spontaneous preterm birth in multiple pregnancies. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1):A5.1–A5A5.
   Google Scholar
• Markova I, Nikolov A, Markov P. Preliminary results of fetal fibronectin testing in twin pregnancies. Akush Ginekol. 2014;53(6):4–8. Bulgarian
   PubMedGoogle Scholar
• Mateus J, Pereira L, Baxter J, et al. Fetal fibronectin compared to cervical dilation in clinical practice [abstract]. Am J Obstet Gynecol. 2003;189:S165.
   Google Scholar
• Mathieu-D’Argent E. Screening strategy of MAP (threat of premature birth): selective use of fetal fibronectin detection. Rev Prat Gynecol Obstet. 2006;102:8 [French].
   Google Scholar
• Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, et al. IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand. 1998;77(7):701–706.
   PubMed Web of Science ®Google Scholar
• McKenna DS, Chung K, Shubert P, et al. The effect of digital examination on the expression of fetal fibronectin [abstract]. Am J Obstet Gynecol. 1998;178:S188.
   Google Scholar
• McParland PC, Bell SC, Malak TM, et al. Fibronectin in cervicovaginal secretions in the prediction of preterm birth. Contemp Rev Obstet Gynaecol. 1997;9:33–41.
   Google Scholar
• McParland PC, Kenyon S, Bell SC, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. Br J Obstet Gynaecol. 2006;113:976. author reply:976–977.
   Google Scholar
• Meints L, Redfield J, Akers D. Effect of limiting intercourse on perinatal outcomes. Reprod Sci. 2016;23(1 Suppl 1):111A.
   Google Scholar
• Meis PJ, Goldenberg RL, Mercer BM, et al. Maternal-Fetal Medicine Units Network of the National institute of child health and human development. The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol. 1998;178(3):562–567.
   PubMed Web of Science ®Google Scholar
• Mercorio F, Mercorio A, Di Spiezio Sardo A, et al. Cervical fetal fibronectin as a predictor of first trimester pregnancy outcome in unexplained recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):165–169.
   PubMed Web of Science ®Google Scholar
• Merriam A, Sciscione A, Daniel L. A prospective evaluation of the effectiveness of vaginal fetal fibronectin to predict preterm birth in women with symptoms of preterm labor in the outpatient setting. Am J Obstet Gynecol. 2014;210(1 Suppl 1):S224.
   PubMed Web of Science ®Google Scholar
• Mi Lee S, Romero R, Park JW, et al. The clinical significance of a positive AmniSure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2012;25(9):1690–1698.
   PubMed Web of Science ®Google Scholar
• Min J, Watson HA, Hezelgrave NL, et al. Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study. Ultrasound Obstet Gynecol. 2016;48(1):38–42.
   PubMed Web of Science ®Google Scholar
• Mogami H, Keller PW, Word RA. Fetal fibronectin-more than matrix support. Reprod Sci. 2011;18(3 Suppl 1):71A.
   Web of Science ®Google Scholar
• Mogami H, Kishore AH, Shi H, et al. Fetal fibronectin extra domain-A (EDA): pathogenesis of preterm labor and preterm rupture of membranes. Reprod Sci. 2012;19(3 Suppl 1):299A.
   Google Scholar
• Mogami H, Kishore AH, Shi H, et al. Fetal fibronectin signaling induces matrix metalloproteases and cyclooxygenase-2 (COX-2) in amnion cells and preterm birth in mice. J Biol Chem. 2013;288(3):1953–1966.
   PubMed Web of Science ®Google Scholar
• Mogami H, Kondo E, Fujita K, et al. Fetal fibronectin is a pathogenic factor of preterm PROM and preterm birth. Placenta. 2013;34(10):A3.
   Web of Science ®Google Scholar
• Moroz L, Simhan H. Serial collection of fetal fibronectin and the risk of spontaneous preterm birth among women with a sonographically short cervix [abstract]. Am J Obstet Gynecol. 2011;204:S201.
   Google Scholar
• Morrison JC, Naef RW, Botti JJ, et al. Uterine activity and fetal fibronectin are independent and combined predictors of spontaneous preterm birth [abstract]. Am J Obstet Gynecol. 1995;172:406.
   Google Scholar
• Morriss AK, Smout E, Shennan A. The use of fetal fibronectin testing in the management of a triplet pregnancy with a short cervix. BMJ Case Rep. 2011;2011.
   Google Scholar
• Most O, Langer O, Kerner R, et al. Can myometrial electrical activity identify patients in preterm labor? Am J Obstet Gynecol. 2008;199(4):378.e1–378.e6.
   Web of Science ®Google Scholar
• Mozurkewich EL, Naglie G, Krahn MD, et al. Predicting preterm birth: a cost-effectiveness analysis. Am J Obstet Gynecol. 2000;182(6):1589–1598.
   PubMed Web of Science ®Google Scholar
• Muller A, McCullough M, Obican S, et al. ‘False ’ positive fetal fibronectin and rates of adverse obstetrical outcomes [abstract]. Am J Obstet Gynecol. 2006;195:S233.
   Google Scholar
• Musaad SM, Melson CL, Boswell DR. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labor at Middlemore Hospital, New Zealand. Pathology. 2005;37(3):226–230.
   PubMed Web of Science ®Google Scholar
• Musaad SM, Melson LC, Boswell RD. Fetal fibronectin assay may reduce management cost of preterm labor: an interval analysis. Pathology. 2006;38(5):473–474.
   PubMed Web of Science ®Google Scholar
• Nageotte MP, Hollenbach KA, Vanderwahl BA, et al. Oncofetal fibronectin in patients at increased risk for preterm delivery [abstract]. Am J Obstet Gynecol. 1992;166(1 Pt 2):274–478.
   PubMedGoogle Scholar
• Nash P. Fetal fibronectin: what does it mean? Neonatal Netw. 2010;29(6):385–387.
   PubMedGoogle Scholar
• Ness A, Visintine J, Ricci E, et al. Use of fetal fibronectin and transvaginal ultrasound cervical length to triage women with suspected preterm labor: a randomized trial [abstract]. Am J Obstet Gynecol. 2006;195:S67.
   Google Scholar
• Nguyen TQ, Toy EC, Baker B. The cost-effectiveness of fetal fibronectin testing in suspected preterm labor: a randomized trial [abstract]. Obstet Gynecol. 2002;99:97S.
   Google Scholar
• Nishida N, Asakura H, Yonezawa M, et al. Prediction of preterm birth in comparison of TVS findings to those with positive fetal fibronectin (fFN). Int J Gynecol Obstet. 2009;107(Suppl 2):S468.
   Google Scholar
• No author listed. Fetal fibronectin – biomarker for preterm labour. Akush Ginekol. 2010;49:39–42 [Bulgarian].
   PubMedGoogle Scholar
• Novakov-Mikić A, Ivanović L, Nikolić A, et al. Levels of fetal fibronectin in the cervix and vagina during pregnancy. Med Pregl. 1999;52(11–12):441–445. Croatian.
   Google Scholar
• Nwokoro I, Forya F, Warner D, et al.   First trimester bacterial vaginosis is associated with mid-gestation short cervical length and positive fFN test, and spontaneous preterm birth in high risk women. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A160.2–A1A160.
   Google Scholar
• O’Byrne L, Daly S. Audit of fetal fibronectin use in a tertiary referral hospital in the triaging of threatened preterm labour. Br J Obstet Gynaecol. 2016;123(Suppl 4):(13–14).
   Google Scholar
• Osorio M, Neiva R, Montes L, et al. The impact of fetal fibronectin assay on preterm labor management: a randomized controlled trial. J Matern Fetal Neonat Med. 2010;23(Suppl 1):304–305.
   Google Scholar
• Owen P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol. 1995;102(12):1019.
   PubMedGoogle Scholar
• Owen P. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol. 1996;103(9):937.
   PubMedGoogle Scholar
• Owen P, Scott A. Can fetal fibronectin testing improve the management of preterm labor? Clin Exp Obstet Gynecol. 1997;24(1):19–22.
   PubMedGoogle Scholar
• Parisaei M, Currie J, O’Gorman N, et al. Implementation of foetal fibronectin testing: admissions, maternal interventions and costs at 1 year. J Obstet Gynaecol. 2016;36(7):888–892.
   PubMedGoogle Scholar
• Parry E, Singh TG, Dow D, et al. Improved management in threatened preterm labor with rapid fetal fibronectin testing. Aust N Z J Obstet Gynaecol. 2006;46(3):240–241.
   PubMed Web of Science ®Google Scholar
• Parry E, Roos C, Stone P, et al. The NIFTY study: a multi-centre randomised double blind placebo controlled trial of nifedipine maintenance tocolysis in fetal fibronectin positive women in threatened preterm labor [abstract]. Am J Obstet Gynecol. 2012;206:S216.
   Google Scholar
• Parry E, Roos C, Stone P, et al. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labor. Aust N Z J Obstet Gynaecol. 2014;54(3):231–236.
   PubMed Web of Science ®Google Scholar
• Pastore LM, Royce RA, Jackson TP, et al. Association between bacterial vaginosis and fetal fibronectin at 24–29 weeks’ gestation. Obstet Gynecol. 1999;93(1):117–123.
   PubMed Web of Science ®Google Scholar
• Paternoster DM, De Paoli M, Plebani M, et al. Risk factors and predictors of preterm delivery. Prenat Neonat Med. 1999;4:308–311.
   Google Scholar
• Paxton A. For fetal fibronectin test, the time is right. CAP Today. 1998;12:76–78, 80, 82, 84, 80, 82, 84.
   Google Scholar
• Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in symptomatic patients: a multicenter trial [abstract]. Am J Obstet Gynecol. 1996;176(1 Suppl):303S.
   Google Scholar
• Peláez L, Fox N, Chasen S. Negative FFN: who is still managed aggressively and does it help? [abstract]. Am J Obstet Gynecol. 2006;195:S233.
   Google Scholar
• Peleva E, Hezelgrave NL, Shennan AH. PPO.07  Evaluation of the effect of cervical cerclage insertion on quantitative cervicovaginal fetal fibronectin levels, and prediction of spontaneous preterm birth. Arch Dis Child Fetal Neonat Ed. 2014;99(Suppl 1):A152.2–A1A152.
   Google Scholar
• Pereira L, Alexender A, Snyder J, et al. Effect of gestational age and serial sampling on the concentration of cervical-vaginal protein biomarkers for preterm birth [abstract]. Am J Obstet Gynecol. 2009;201:S185.
   Google Scholar
• Perin A, Beltrame G, Marcon G, et al. Fetal fibronectin measured in cervicovaginal secretions in physiological preterm pregnancies: relation with the delivery. Eur J Lab Med. 1997;5(1):35–38.
   Google Scholar
• Peterson WE, Sprague AE, Reszel J, et al. Women’s perspectives of the fetal fibronectin testing process: a qualitative descriptive study. BMC Pregnancy Childbirth. 2014;14:190.
   Google Scholar
• Pieta-Dolińska A, Jaczewski B, Woźniak P, et al. Assessment of fetal fibronectin concentration in identifying patients at risk for preterm delivery. Ginekol Pol. 2005;76(6):431–435. Polish
   PubMedGoogle Scholar
• Plaut M. Fetal fibronectin and the safety of outpatient management of preterm labor symptoms. Am J Obstet Gynecol. 1996;174(2):797–798.
   PubMed Web of Science ®Google Scholar
• Plaut M, Smith W, Kennedy K. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms. Am J Obstet Gynecol. 2003;188:1588–93; discussion 1593. discussion:1593–1595.
   Google Scholar
• Ponting J, Tomlin M. Diagnosis of preterm labor: introducing the fetal fibronectin test. Br J Midwif. 2011;19:700–707.
   Google Scholar
• Pütz I, Winkler M, Rath W. Zuverlässigkeit Des Nachweises von fetalem fibronectin mit Hilfe Des monoklonalen Antikörpers FDC-6 [Reliability of the detection of fetal fibronectin using monoclonal antibody FDC-6]. Geburtshilfe Frauenheilkd. 1995;55(12):703–706.
   PubMed Web of Science ®Google Scholar
• Quintieri F, Paternoster D, Plebani M, et al. Fetal fibronectin as a predictor of preterm delivery [abstract]. Int J Gynecol Obstet. 1994;46(1 Suppl):145S.
   PubMed Web of Science ®Google Scholar
• Radford S, Abbott D, Seed P, et al. The use of fetal fibronectin from 18 weeks in the prediction of preterm birth in high-risk asymptomatic women. Arch Dis Child Fetal Neonat Ed. 2012;97(Suppl 1):A74.2–A7A74.
   Google Scholar
• Radford S, Abbott D, Seed P, et al. Quantitative fetal fibronectin for the prediction of preterm birth in symptomatic women. Arch Dis Child Fetal Neonat Ed. 2012;97(Suppl 1):A73.2–A7A73.
   Google Scholar
• Radford S, Smith J, Shennan A, et al. Interhospital transfers of women in threatened preterm labour to Victorian level 6 hospitals. J Paediatr Child Health. 2015;51(Suppl 1):51.
   Google Scholar
• Radford S, Costa FDS, Junior EA, et al. Clinical application of quantitative fetal fibronectin for the prediction of preterm birth in symptomatic women [abstract]. Br J Obstet Gynaecol. 2016;123(S2):158–159.
   Google Scholar
• Ramírez Pineda M, Dueñas Díez JL, Sala Turrens J, et al. Analysis of two strategies for the management of threatened preterm labor. Progr Obstet Ginecol. 2010;53(7):261–266. Spanish
   Google Scholar
• Ramsey PS, Andrews WW. Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clin Perinatol. 2003;30(4):701–733.
   PubMed Web of Science ®Google Scholar
• Ramsey P. Relationship of midtrimester fetal fibronectin (FFN) concentration to antibiotic efficacy for the prevention of spontaneous preterm birth in asymptomatic FFN positive women [abstract]. Am J Obstet Gynecol. 2004;191:S11.
   Google Scholar
• Ramsey PS. Fetal fibronectin results did not reduce medical resource use for women with preterm uterine contractions. Evid Based Obstet Gynecol. 2005;7:118–119. [2005. Letter, Grobman WA, Welshman EE, Calhoun EA].
   Google Scholar
• Rehbock J, Gloning KP. Fetales Fibronektin als prädiktiver Faktor der drohenden Frühgeburt [Fetal fibronectin as a predictive factor of threatened premature labor]. GynäkolGeburtshilfliche Rundsch. 1993;33:191–192.
   Google Scholar
• Ridout A, Carter J, Shennan A. Clinical utility of quantitative fetal fibronectin in preterm labor. BJOG. 2016;123(12):1972.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Rinaldo D, et al. Fetal fibronectin in cervical secretions after mid-trimester amniocentesis. Prenat Diagn. 1995;15(11):1087–1088.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Arduini D, et al. The prognostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor [abstract]. Am J Obstet Gynecol. 1997;176:S6.
   Google Scholar
• Roberts WE, Morrison JC. Has the use of home monitors, fetal fibronectin, and measurement of cervical length helped predict labor and/or prevent preterm delivery in twins? Clin Obstet Gynaecol. 1998;41(1):94–102.
   Web of Science ®Google Scholar
• Roman AS, Rebarber A, Lipkind H, et al. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction. Am J Obstet Gynecol. 2004;190(1):142–146.
   PubMed Web of Science ®Google Scholar
• Roman A, Fox N, Klauser C, et al. Fetal fibronectin as a predictor of spontaneous preterm birth in triplet gestations [abstract]. Am J Obstet Gynecol. 2011;204:S186.
   Google Scholar
• Roos C. Does fibronectin status influence the effectiveness of sustained tocolysis in women with threatened preterm labor? J Matern Fetal Neonat Med. 2012;25(Suppl 2):46–47.
   Google Scholar
• Roos C, Schuit E, Scheepers HCJ, et al. for APOSTEL-II Study Group. Predictive factors for delivery within 7 days after successful 48-hour treatment of threatened preterm labor. Am J Perinatol Rep. 2015;5:e141–ee149.
   Google Scholar
• Ross GN, Ridout AE, Shennan AH. Optimal clinical risk prediction can be achieved by combining quantitative fetal fibronectin and cervical length, and avoiding thresholds. Acta Obstet Gynecol Scand. 2016;95(8):956.
   PubMed Web of Science ®Google Scholar
• Ross G, Ridout A, Seed P, et al. Pzredicting preterm birth in high-risk women with prophylactic intervention in situ: a large prospective series. Br J Obstet Gynaecol. 2017;124(Suppl 2):40–41.
   Google Scholar
• Rossel Goffeng A, Holst E, Milsom I, et al. Fetal fibronectin and microorganisms in vaginal fluid of healthy pregnant women. Acta Obstet Gynecol Scand. 1996;75(6):520–525.
   PubMed Web of Science ®Google Scholar
• Rossel Goffeng A, Holst E, Milsom I, et al. Factors influencing vaginal fetal fibronectin concentrations during pregnancy. Gynecol Obstet Invest. 1999;47(2):83–88.
   PubMed Web of Science ®Google Scholar
• Rouse DJ. Improved management in threatened preterm labor with rapid fetal fibronectin testing: commentary. Obstet Gynecol Surv. 2006;61:688–689.
   Google Scholar
• Ruiz RJ, Fullerton J, Brown CE, et al. Relationships of cortisol, perceived stress, genitourinary infections, and fetal fibronectin to gestational age at birth. Biol Res Nurs. 2001;3(1):39–48.
   PubMedGoogle Scholar
• Sadovsky Y, Friedman SA. Fetal fibronectin and preterm labor. N Engl J Med. 1992;326(10):709.
   PubMed Web of Science ®Google Scholar
• Salafia C, Hardy G, Wahl E, et al. Cervicovaginal fibronectin levels: clinical and pathologic correlations [abstract]. Am J Obstet Gynecol. 1993;168(1 Suppl):372S.
   Google Scholar
• Salari K, Treadwell M, Thompson K. Predictors of preterm birth: a comparison of cervical length, fetal fibronectin and fetal adrenal gland enlargement [abstract]. Am J Obstet Gynecol. 2015;212(1):S179–S180.
   PubMed Web of Science ®Google Scholar
• Salcedo A, Kurtzman J. Digital cervical exam characteristics stratify the risk of preterm birth based on fetal fibronectin status [abstract]. Am J Obstet Gynecol. 2013;208:S203.
   Google Scholar
• Sanchez-Ramos L. The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes. Obstet Gynecol. 2003;102:196. author reply:196.
   Google Scholar
• Sanchez-Ramos L, Delke I, Kaunitz AM. Cervico-vaginal fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis of diagnostic accuracy [abstract]. Am J Obstet Gynecol. 2007;197:S198.
   Google Scholar
• Schindhelm RK, Hoogenberg J, de Vos MT, et al. Analytical performance of quantitative fetal fibronectin assay. Ultrasound Obstet Gynecol. 2016;47(1):127.
   PubMed Web of Science ®Google Scholar
• Schmiedel D, Fischer T, Von Tucher E, et al. Combination of cervical sonoelastography with cervical length measurement and fetal fibronectin to improve prediction of preterm birth. Ultraschall Med. 2013;34(Suppl 1) WS_SL6_07. DOI:10.1055/s-0033-1354839.
   Google Scholar
• Sénéclauze-Seguin V, Fritz G, Langer B. Intérêt de la fibronectin couplée à la mesure échographique du col utérin en cas de menace d’accouchement prématuré [Importance of the fibronectin doubled with ultrasound measurement of cervix in case of threat of preterm labor]. Rev Med Perinat. 2013;5/1:43–48 [French].
   Google Scholar
• Sheehan A, Brennecke S, Boland R, et al. The use of fetal fibronectin testing in clinical practice: an audit of referrals for threatened preterm labour to the Victorian perinatal emergency retrieval service from non-tertiary hospitals. J Paediatr Child Health. 2017;53(Suppl 2):90.
   Google Scholar
• Shennan AH. Advances in fetal fibronectin. Br J Obstet Gynaecol. 2015;122(Suppl 2):371.
   Google Scholar
• Shimoya K, Hashimoto K, Shimizu T, et al. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions. Am J Obstet Gynecol. 1998;179(1):255–256.
   PubMed Web of Science ®Google Scholar
• Siassakos D, O’Brien K, Draycott T. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour. J Obstet Gynaecol. 2009;29(6):507–511.
   PubMedGoogle Scholar
• Siddiqa M, Haloob R. An audit of fetal fibronectin test. Int J Gynecol Obstet. 2012;119(Suppl 3):S752.
   Google Scholar
• Simhan H. Comparison of self-collected vs speculum-collected measurement of quantitative fetal fibronectin [abstract]. Am J Obstet Gynecol. 2016;214(1):S310–S311.
   Web of Science ®Google Scholar
• Simpson NA. Comment on: development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women. K. Kuhrt, et al. Ultrasound Obstet Gynecol. 2016;47:15-6:104–109.
   PubMed Web of Science ®Google Scholar
• Skałba P, Kamiński K, Bilski T. Fetal fibronectin as a predictor of threatening preterm delivery. Przegl Lek. 1992;49(10):350–351. Polish.
   PubMedGoogle Scholar
• Smout EM, Seed PT, Shennan AH. The development of an iPhone application to predict preterm birth in high risk women. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa124.
   Google Scholar
• Smout EM, Seed PT, Shennan AH. Fetal fibronectin as a predictor of PTB in primiparous women with cervical surgery. J Matern Fetal Neonatal Med. 2010;23(Suppl 1):306–307.
   Google Scholar
• Spiegelman J, Booker W, Gupta S, et al. The independent association of a short cervix, positive fetal fibronectin, amniotic fluid sludge, and cervical funneling with spontaneous preterm birth in twin pregnancies. Am J Perinatol. 2016;33(12):1159–1164.
   PubMed Web of Science ®Google Scholar
• Stafford I, Dildy G. Can fetal fibronectin be reliably without speculum examination? [abstract]. Am J Obstet Gynecol. 2005;193:S63.
   Google Scholar
• Stafford IP, Garite TJ, Dildy GA, et al. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein 1 (pIGFBP-1) test and fibronectin test. Ann Acad Med Singapore. 2007;36:399–402.
   Google Scholar
• Stafford IP, Garite TJ, Dildy GA, et al. A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol. 2008;199(2):131.e1–131.e4.
   Web of Science ®Google Scholar
• Stern V, Healey J, Brown B, et al. Assessing the risk of spontaneous premature birth by electrical impedance spectroscopy of the cervix: the ecclippx study. Reprod Sci. 2015;22(Suppl 1):331A.
   Google Scholar
• Stern V, Amabebe E, Anumba D. The association between cervicovaginal fetal fibronectin, the metabolic markers of the vaginal microbiome, and preterm birth. Br J Obstet Gynaecol. 2016;123(Suppl 1):79–80.
   Google Scholar
• Stern V, Anumba D. Screening for preterm birth with serial cervical length measurement and fetal fibronectin quantification-does rate of change predict early delivery? Br J Obstet Gynaecol. 2016;123(Suppl 1):80.
   Google Scholar
• Stern V, Amabebe E, Reynolds S, et al. The association of cervicovaginal fluid metabolites at 20–22 weeks gestation with quantitative fetal fibronectin, ultrasound cervical length and gestational age at delivery in asymptomatic pregnant women. Reprod Sci. 2016;23(1 Suppl 1):190A–191A.
   Google Scholar
• Stern V, Anumba DOC. Predicting preterm birth. The performance of ultrasound cervical length, quantitative fetal fibronectin and vaginal fluid ph differs by risk of preterm birth and symptoms of preterm labour. Reprod Sci. 2016;23(1 Suppl 1):106A.
   Google Scholar
• Sullivan A, Hueppchen NA, Satin AJ. Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm. J Matern Fetal Med. 2001;10(6):380–384.
   PubMedGoogle Scholar
• Sullivan E, Shen X, Petrilla A, et al. Use of screening tools and patterns of healthcare utilization among pregnant women diagnosed with preterm labor in the U.S. Emergency Department setting. Value Health. 2017;20(5):A251.
   PubMed Web of Science ®Google Scholar
• Swamy G, Simhan H, Seglin H, et al. The clinical utility of fetal fibronectin [abstract]. Am J Obstet Gynecol. 2001;184:S136.
   Google Scholar
• Swancoat S. ‘Recent vaginal exam’ no longer a contraindication to fetal fibronectin sampling: a prospective study. Obstet Gynecol. 2016;127(Suppl 1):16S.
   Web of Science ®Google Scholar
• Tanir HM, Sener T, Yildiz Z. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study. Clin Exp Obstet Gynecol. 2008;35(1):61–64.
   PubMed Web of Science ®Google Scholar
• Tchobroutsky C. La fibronectin foetale dans les sécrétions cervico-vaginales: prédiction de l’accouchement prématuré et à terme [Fetal fibronectin in cervico-vaginal secretions: prediction of premature and term delivery]. Contracept Fertil Sex. 1998;26(1):23–25 [French].
   PubMedGoogle Scholar
• Tekesin I, Wallwiener D, Schmidt S. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery. J Perinat Med. 2005;33(5):383–391.
   PubMed Web of Science ®Google Scholar
• Teoh PJ, Ridout A, Seed P, et al. Does urinary tract infection alter fetal fibronectin vaginal swab results? [letter to Editor]. Eur J Obstet Gynecol Reprod Biol. 2018;222:184–185.
   Google Scholar
• Thandayathany V, Yassin MAJM, Omar MH. Fetal fibronectin rapid test versus phosphorylated insulin-like growth factor-1 (phIGFBP-1) as bedside test kits for prediction of preterm delivery in the clinical setting. Br J Obstet Gynaecol. 2012;119(Suppl 1):5.
   Google Scholar
• Tsoi E, Akmal S, Geerts L, et al. Sonographic measurement of cervical length ad fetal fibronectin testing in threatened preterm labor [letter]. Obstet Gynecol Surv. 2006;61(7): 441–442.
   Google Scholar
• Turitz AL, Ackerman CM, Johnson DL, et al. A comparison of pre and post-vaginal manipulation fetal fibronectin [abstract]. Am J Obstet Gynecol. 2016;214(1):S10–S11.
   Web of Science ®Google Scholar
• Turitz AL, Ackerman CM, Johnson DL, et al. A comparison of prevaginal and postvaginal manipulation fetal fibronectin. Am J Obstet Gynecol. 2016;214(5):646.e1–646.e6.
   Web of Science ®Google Scholar
• Turitz AL, Ananth C, Gyamfi-Bannerman C. A comparison of quantitative pre and post-vaginal manipulation fetal fibronectin. Am J Obstet Gynecol. 2017;216(1 Suppl 1):S197.
   Web of Science ®Google Scholar
• Ugwumadu A, Yanamandra N, Hay P. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG. 2006;113(7):851–852.
   PubMed Web of Science ®Google Scholar
• van Baaren G-J, Vis J, Wilms F, et al. Economic analysis of fetal fibrinectin testing and/or cervical length measurement in women with threatened preterm labor. Am J Obstet Gynecol. 2013;208(1 Suppl 1):S210–SS211.
   Web of Science ®Google Scholar
• van Baaren GJ, Vis JY, Grobman WA, et al. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor. Am J Obstet Gynecol. 2013;209(5):436.e1–436.e8.
   Web of Science ®Google Scholar
• van Baaren G-J, Vis J, Wilms F, et al. The accuracy of fetal fibronectin and cervical length in women with signs of preterm labor before 34 weeks: a nationwide cohort study in the Netherlands (APOSTEL1 study) [abstract]. Am J Obstet Gynecol. 2013;208:S8.
   Google Scholar
• van Baaren G-J, Vis J, Wilms F, et al. The risk of preterm delivery in women with signs of preterm labor before 34 weeks who do not deliver within 7 days: the APOSTEL-1 cohort. Am J Obstet Gynecol. 2014;210(1 Suppl 1):S375.
   Web of Science ®Google Scholar
• van Baaren G-J, Bruijn M, Vis J, et al. False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute? [abstract]. Am J Obstet Gynecol. 2014;210:S395.
   Google Scholar
• van Baaren GJ, Bruijn MMC, Vis JY, et al. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women? Eur J Obstet Gynecol Reprod Biol. 2015;192:79–85.
   Google Scholar
• van Baaren GJ, Bruijn MMC, Mol BW. Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing. Am J Obstet Gynecol. 2018;218(1):142–143.
   PubMed Web of Science ®Google Scholar
• van der Krogt L, Ridout A, Seed P, et al. Placental inflammation and cervicovaginal fetal fibronectin in women who deliver preterm; the potential to predict aetiology [abstract]. BJOG. 2016; RCOG World Congress 2016 22-26/6 Birmingham UK.
   Google Scholar
• van der Krogt L, Hezelgrave NL, Seed PT, et al. Prediction of spontaneous preterm birth using fetal fibronectin in women with a low-lying placenta. J Matern Fetal Neonatal Med. 2017;30(3):313–316.
   PubMed Web of Science ®Google Scholar
• van der Krogt L, Hezelgrave N, Seed P, et al. Prediction of spontaneous preterm birth using fetal fibronectin in women with a low-lying placenta. Br J Obstet Gynaecol. 2016;123:Suppl 2:85.
   Google Scholar
• van der Krogt L, Ridout AE, Seed PT, et al. Placental inflammation and its relationship to cervicovaginal fetal fibronectin in preterm birth. Eur J Obstet Gynecol Reprod Biol. 2017;214:173–177.
   Google Scholar
• Vandermolen B, Hezelgrave N, Seed P, et al. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women with previous cervical surgery. Br J Obstet Gynaecol. 2016;123(Suppl 2):85–86.
   Google Scholar
• Vandermolen BI, Hezelgrave NL, Smout EM, et al. Quantitative fetal fibronectin and cervical length to predict preterm birth in asymptomatic women with previous cervical surgery. Am J Obstet Gynecol. 2016;215(4):480.e1–480.e10.
   PubMed Web of Science ®Google Scholar
• Velasco JG, González González A. Fibronectin and prevention of premature labor. Med Clin (Barc). 1995;105(2):54–55. Spanish.
   PubMed Web of Science ®Google Scholar
• Verspyck E, Roman H, Marpeau L. Marqueurs biochimiques de la menace d’accouchement prématuré (en dehors de l’infection) [Biochemical markers for preterm delivery (excepting markers of infection)]. J Gynecol Obstet Biol Reprod. 2002;31(7 Suppl):S35–S42 [French].
   Google Scholar
• Vis JY, Wilms FF, Oudijk MA, et al. Cost effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-1 trial). BMC Pregnancy Childbirth. 2009;9:38.
   Google Scholar
• Vis JY, Wilms FF, Oudijk MA, et al. Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designs. Am J Perinatol. 2011;28(2):145–150.
   PubMed Web of Science ®Google Scholar
• Vis JY, Opmeer B, van der Post J, et al. Does fibronectin status influence the effectiveness of sustained tocolysis in women with threatened preterm labor? [abstract]. Am J Obstet Gynecol. 2011;204:S199–S200.
   Google Scholar
• Vis JY, van Baaren GJ, Wilms FF, et al. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial). Am J Perinatol. 2015;32(5):451–460.
   PubMed Web of Science ®Google Scholar
• Vogel I, Thorsen P, Curry A, et al. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand. 2005;84(6):516–525.
   PubMed Web of Science ®Google Scholar
• Vousden N, Hezelgrave N, Abbott D, et al. Quantitative fetal fibronectin as a predictor of preterm birth in asymptomatic women with trans-abdominal cerclage. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1):(A32). DOI:10.1136/archdischild-2013-303966.107.
   Google Scholar
• Vousden N, Hezelgrave N, Abbott D, et al. The use of quantitative fetal fibronectin to predict obstetric outcome: a comparison of a new and established quantitative bedside analyser in asymptomatic high-risk women. Arch Dis Child Fetal Neonat Ed. 2013;98(Suppl 1):(A42). DOI:10.1136/archdischild-2013-303966.143.
   Google Scholar
• Watson DL, Kim SJ, Humphrey MD. Study of cervicovaginal fetal fibronectin status to guide treatment of threatened preterm labor. Aust N Z J Obstet Gynaecol. 1998;38(2):185–187.
   PubMed Web of Science ®Google Scholar
• Watson H, Min J, Hezelgrave N, et al. Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study. Br J Obstet Gynaecol. 2016;123:(Suppl 2):167–168.
   Google Scholar
• Watson HA, Ridout A, Ross G. Decision-making about preterm birth using the QUIPP app: a survey of women’s experiences. Br J Obstet Gynaecol. 2017;124(Suppl 2):132–140.
   Google Scholar
• Watson HA, Carter J, Seed PT, et al. The QUIPP App: a safe alternative to a teat-all strategy for threatened preterm labor. Ultrasound Obstet Gynecol. 2017;50(3):342–346.
   PubMed Web of Science ®Google Scholar
• Watts E, Hezelgrave NL, Oteng-Ntim E, et al. Foetal fibronectin and cervical length measurement folowing Arabin pessary insertion in a high-risk twin pregnancy: a case report. J Obstet Gynaecol. 2017;37(1):103–104.
   PubMedGoogle Scholar
• Wetta L, Owen J, Szychowski J, et al. Mid-trimester cervical shortening: before and after cervicovaginal fluid analysis in women with prior spontaneous preterm birth. Am J Obstet Gynecol. 2017;216(1 Suppl 1):S182.
   Web of Science ®Google Scholar
• Wetta L, Owen J, Szychowski J, et al. Mid-trimester cervical shortening in women with a prior spontaneous preterm birth: association with quantitative fetal fibronectin concentrations. Am J Obstet Gynecol. 2017;216(1 Suppl 1):S183.
   PubMed Web of Science ®Google Scholar
• White H, Hodgetts-Morton V, Stock S, et al. Quantitative fibronectin to help decision making in women with symptoms of preterm labour: determining decisional requirements (QUIDS Qualitative). Br J Obstet Gynaecol. 2017;124(Suppl 1):58–59.
   Google Scholar
• Wilms FF, Vis JY, de Wit-Zuurendonk L, et al. What is the risk of preterm delivery after arrested preterm labor? Am J Perinatol. 2015;32(1):63–70.
   PubMed Web of Science ®Google Scholar
• Wilms FF, Van Baaren GJ, Vis JY, et al. Prescribing patterns of antenatal corticosteroids in women with threatened preterm labor. Eur J Obstet Gynecol Reprod Biol. 2015;192:47–53.
   Google Scholar
• Wiqvist N. Analysis of fetal fibronectin in cervical and vaginal secretions can predict preterm labor. Lakartidningen. 1992;89(30–31):2495 [Swedish].
   PubMedGoogle Scholar
• Wiqvist N. Fetal fibronectin and preterm birth. Acta Obstet Gynecol Scand. 1993;72(7):507–508.
   PubMed Web of Science ®Google Scholar
• Wong CH, Chen CP, Chang CC, et al. Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth. Sci Rep. 2017;7(7):42461.
   PubMed Web of Science ®Google Scholar
• Woodworth A, Moore J, G’Sell C, et al. Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-6: albumin ratio as markers of preterm delivery. Clin Chem. 2007;53(8):1534–1540.
   PubMed Web of Science ®Google Scholar
• Woodworth A, Grenache DG, Gronowski AM. Cervicovaginal interleukin-6 as a predictor of preterm birth in African American women. Clin Chim Acta. 2011;412(11–12):988–992.
   Web of Science ®Google Scholar
• Woźniak S, Sikorski R, Krzemiński A, et al. Fibronectin pattern in the first and second trimester of normal pregnancy. Ginekol Pol. 1998;69(12):930–936. Polish.
   PubMedGoogle Scholar
• Woźniak S, Sikorski R, Krzemiński A, et al. Levels of fetal and plasma fibronectin in patients with cervical incompetence. Ginekol Pol. 2001;72(12):1144–1148. Polish.
   PubMedGoogle Scholar
• Yeast JD, Lu G. Biochemical markers for the prediction of preterm delivery. Clin Perinatol. 2007;34(4):573–586, vi.
   PubMed Web of Science ®Google Scholar
• Yoneda S, Shiozaki A, Yoneda N, et al. Prediction of exact delivery time in patients with preterm labor and intact membranes at admission by amniotic fluid interleukin-8 level and preterm labor index. J Obstet Gynaecol Res. 2011;37(7):861–866.
   PubMed Web of Science ®Google Scholar
• Yoneyama K, Kimura A, Kogo M, et al. Clinical predictive factors for preterm birth in women with threatened preterm labor or preterm premature ruptured membranes? Aust N Z J Obstet Gynaecol. 2009;49(1):16–21.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Moon JB, et al. The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin. Am J Obstet Gynecol. 2001;185(5):1137–1142.
   PubMed Web of Science ®Google Scholar
• Zork N, Holland A, Pessel C, et al. A negative fetal fibronectin is still reassuring in asymptomatic women with a transvaginal cervical length <10 mm. Reprod Sci. 2013;20(3)(Suppl 1):199A.
   Google Scholar
• Abbott DS, Radford SK, Seed PT, et al. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol. 2013;208(2):122.e1–122.e6.
   Web of Science ®Google Scholar
• Abbott DS, Hezelgrave NL, Seed PT, et al. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Obstet Gynecol. 2015;125(5):1168–1176.
   PubMed Web of Science ®Google Scholar
• Abenhaim HA, Morin L, Benjamin A. Does availability of fetal firbonectin testing in the management of threatened preterm labor affect the utilization of hospital resources? J Obstet Gynaecol Can. 2005;27(7):689–694.
   PubMedGoogle Scholar
• Ai F, Li GQ, Jiang J, et al. Neutrophil elastase and fetal fibronectin levels as predictors of single-birth prematurity. Exp Ther Med. 2015;10(2):665–670.
   PubMed Web of Science ®Google Scholar
• Akers A, Jarzembowski JA, Johnson CT, et al. Examining the relationship between positive mid-gestational fetal fibronectin assays and histological evidence of acute placental inflammation. J Perinat Med. 2007;35(1):36–42.
   PubMed Web of Science ®Google Scholar
• Anwar A, Lindow SW, Greaves L, et al. The use of fetal fibronectin in suspected pre-term labor. J Obstet Gynaecol. 2014;34(1):45–47.
   PubMedGoogle Scholar
• Arinami Y, Hasegawa I, Takakuwa K, et al. Prediction of preterm delivery by combined use of simple clinical tests. J Matern Fetal Med. 1999;8(2):70–73.
   PubMedGoogle Scholar
• Armson A, Dodds L, Dooley K, et al. Fetal fibronectin testing for suspected preterm labor in Nova Scottia [abstract]. Am J Obstet Gynecol. 2004;194:S115.
   Google Scholar
• Asakura H, Fukami T, Kurashina R, et al. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin. Gynecol Obstet Invest. 2009;68(1):1–8.
   PubMed Web of Science ®Google Scholar
• Audibert F, Fortin S, Delvin E, et al. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labor. J Obstet Gynaecol Can. 2010;32(4):307–312.
   PubMedGoogle Scholar
• Ayala-Mendez JA, Kurtzman J, Rosalez-Ortiz S, et al. Fetal fibronectin status markedly modifies the risk of preterm delivery in low risk patients with symptomatic preterm labor and cervical shortening [abstract]. Am J Obstet Gynecol. 2008;199:S235.
   Google Scholar
• Bartnicki J, Casal D, Kreaden US, et al. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol. 1996;174(3):971–974.
   PubMed Web of Science ®Google Scholar
• Belisle E, Gawade P, Knee A, et al. Do pregnancies complicated by preterm births with a negative fetal fibronectin screen have different characteristics compared to those that have positive fibronectin results? [abstract]. Am J Obstet Gynecol. 2011;204:S190.
   Google Scholar
• Benabid D, Malagrida L, Chraibi T, et al. Dépistage des grossesses à risques d’accouchement prématuré par la détection de la fibronectin foetale: comparaison de 2 tests qualitatif et semi-quantitatif. SPECTRA Biol. 1996;15:51–54 [French].
   Google Scholar
• Benattar C, Taieb J, Fernandez H, et al. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol. 1997;72(2):131–135.
   PubMed Web of Science ®Google Scholar
• Benson JE, Ghidini A, Landy HJ, et al. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage? [abstract]. Am J Obstet Gynecol. 2009;201(6):S68–S69.
   PubMed Web of Science ®Google Scholar
• Benson JE, Landy HJ, Ghidini A, et al. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage. J Matern Fetal Neonatal Med. 2012;25(11):2330–2332.
   PubMed Web of Science ®Google Scholar
• Bittar RE, Yamasaki AA, Sasaki S, et al. Cervical fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol. 1996;175(1):178–181.
   PubMed Web of Science ®Google Scholar
• Boddy M. Fetal fibronectin in high order multiple pregnancies [abstract]. Am J Obstet Gynecol. 2002;187:S123.
   Google Scholar
• Bolt LA, Chandiramani M, De Greeff A, et al. Does fetal fibronectin testing change patient management in women at risk of preterm labor? Eur J Obstet Gynecol Reprod Biol. 2009;146(2):180–183.
   PubMed Web of Science ®Google Scholar
• Briery CM, Chauhan SP, Magann EF, et al. Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients. J Miss State Med Assoc. 2011;52(3):72–75.
   PubMedGoogle Scholar
• Bruijn MM, Kamphuis EI, Hoesli IM, et al. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women. Am J Obstet Gynecol. 2016;215(6):793.e1–793.e8. [pii: S0002-9378(16)30577-4].
   Web of Science ®Google Scholar
• Bruijn MM, Vis JY, Wilms FF, et al. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women. BJOG. 2016;123(12):1965–1971.
   PubMed Web of Science ®Google Scholar
• Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor. Am J Obstet Gynecol. 1995;173(4):1258–1262.
   PubMed Web of Science ®Google Scholar
• Burwick RM, Zork NM, Lee GT, et al. Cervilenz assessment of cervical length compared to fetal fibronectin in the prediction of preterm delivery in women with threatened preterm labor. J Matern Fetal Neonatal Med. 2011;24(1):127–131.
   PubMed Web of Science ®Google Scholar
• Calda P, Cibula D, Doudová D, et al. Fetální fibronektin v cerviko-vaginálním sekretu –indikátor pocínajícího predcasného porodu metodou membránové imunoeseje [Foetal fibronectin in the cervico-vaginal secretion –an indicator of incipient premature delivery by the method of membrane immunoassay]. Cesk Gynekol. 1995;60(6):293–295 [Czech].
   Google Scholar
• Centra M, Coata G, Picchiassi E, et al. Evaluation of quantitative fFn test in predicting the risk of preterm birth. J Perinat Med. 2016;45:91–98.
   Google Scholar
• Chang TC, Chew TS, Pang M, et al. Cervicovaginal foetal fibronectin in the prediction of preterm labor in a low-risk population. Ann Acad Med Singapore. 1997;26(6):776–780.
   PubMedGoogle Scholar
• Cheung KW, Ngu SF, Lee CP. Fetal fibronectin test on Chinese women with symptoms of preterm labor: a pilot study. Hong Kong Med J. 2013;19(5):424–428.
   PubMed Web of Science ®Google Scholar
• Chuileannain FN, Bell R, Brennecke S. Cervicovaginal fetal fibronectin testing in threatened preterm labor –translating research findings into clinical practice. Aust N Z J Obstet Gynaecol. 1998;38(4):399–402.
   PubMed Web of Science ®Google Scholar
• Clock C, Kurtzman J. Positive fetal fibronectin status is associated with dynamic cervical shortening in patients with normal baseline cervical length and symptomatic contractions [abstract]. Am J Obstet Gynecol. 2007;197:S199.
   Google Scholar
• Closset E, Dufour P, Coeugnet C, et al. Intérêt de la recherche de fibronectin foetale pour la prédiction de l’accouchement prématuré [Value of fetal fibronectin research for predicting premature delivery]. Gynecol Obstet Fertil. 2001;29(11):808–813 [French].
   PubMedGoogle Scholar
• Coleman MA, McCowan LM, Pattison NS, et al. Fetal fibronectin detection in preterm labor: evaluation of a prototype bedside dipstick technique and cervical assessment. Am J Obstet Gynecol. 1998;179(6 Pt 1):1553-8:1553–1558.
   PubMed Web of Science ®Google Scholar
• Coleman MA, Keelan JA, McCowan LM, et al. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol. 2001;95(2):154–158.
   PubMed Web of Science ®Google Scholar
• Combs CA, Garite TJ, Maurel K, et al. Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate. Am J Perinatol. 2014;31(12):1023–1030.
   PubMed Web of Science ®Google Scholar
• Cooper S, Lange I, Wood S, et al. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol. 2012;32(6):460–465.
   PubMed Web of Science ®Google Scholar
• Cox S, Little B, Dax J, et al. Fetal fibronectin and preterm delivery [abstract]. Am J Obstet Gynecol. 1996;176(1 Suppl):306S.
   Google Scholar
• Crane JM, Armson BA, Dodds L, et al. Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery. Obstet Gynecol. 1999;93(4):517–522.
   PubMed Web of Science ®Google Scholar
• Deplagne C, Maurice-Tison S, Coatleven F, et al. Utilisation séquentielle de la longueur échographique du col utérin puis de la détection de la fibronectin foetale pour prédire une prématurité spontanée en cas de menace d’accouchement prématuré [Sequential use of cervical length measurement before fetal fibronectin detection to predict spontaneous preterm delivery in women with preterm labor]. J Gynecol Obstet Biol Reprod. 2010;39(7):575–583 [French].
   PubMedGoogle Scholar
• Deplagne C, Maurice-Tison S, Coatleven F, et al. Valeur prédictive du couplage de la fibronectin à l’échographie du col chez les grossesses gémellaires [Predictive value of combined fibronectin and ultrasound cervical assessment in twin pregnancies]. Gynecol Obstet Fertil. 2013;41(5):289–296.
   PubMedGoogle Scholar
• Desjardins PR, Dansereau J. Comparing the clinical effectiveness of Fetal fibronectin and IGFBP-1 measurements in cervico-vaginal secretions, in predicting preterm deliveries. Clin Chem. 2008;54:A-39–A-A40.
   Google Scholar
• Díaz J, Chedraui P, Hidalgo L, et al. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador. J Matern Fetal Neonatal Med. 2009;22(2):89–93.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Giardina I, Coata G, et al. La identificazione del travaglio pretermine : ruolo della fibronectina e della cervicometria ecografica e loro associazione [Identification of preterm labor: the role of the fibronectin and ultrasound cervicometry and their association]. Minerva Ginecol. 2011;63(6):477–483[ Italian].
   PubMedGoogle Scholar
• Di Stefano L, Carta G, Di Paolantonio L, et al. Preterm delivery: predictive value of cervico-vaginal fetal fibronectin. Clin Exp Obstet Gynecol. 1999;26(3–4):187–189.
   Google Scholar
• Dong X, Iwashita M, Ai F, et al. Clinical application of the combined determination of neutrophil elastase, fetal fibronectin, and cervical length in predicting preterm birth of twin pregnancies. Biomed Res. 2017;28:4688–4695.
   Google Scholar
• Duhig KE, Chandiramani M, Seed PT, et al. Fetal fibronectin as a predictor of spontaneous preterm labor in asymptomatic women with a cervical cerclage. BJOG. 2009;116(6):799–803.
   PubMed Web of Science ®Google Scholar
• Dutta D, Norman JE. Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labor: a randomised controlled trial of obstetric and neonatal outcomes. Arch Gynecol Obstet. 2011;284(3):559–565.
   PubMed Web of Science ®Google Scholar
• Eroglu D, Yanik F, Oktem M, et al. Prediction of preterm delivery among women with threatened preterm labor. Gynecol Obstet Invest. 2007;64(2):109–116.
   PubMed Web of Science ®Google Scholar
• Farag AH, Mohammed MM, Ellaithy MI, et al. Blind vaginal fetal fibronectin swab for prediction of preterm birth. J Obstet Gynaecol Res. 2015;41(7):1009–1017.
   PubMed Web of Science ®Google Scholar
• Faron G, Boulvain M, Lescrainier JP, et al. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? BJOG. 1997;104(6):697–701.
   Web of Science ®Google Scholar
• Faron G, Buyl R, Foulon W. Does recent sexual intercourse during pregnancy affect the results of the fetal fibronectin rapid test? A comparative prospective study. J Perinat Med. 2015;43(4):403–408.
   PubMed Web of Science ®Google Scholar
• Florjański J, Kłósek A, Zalewski J, et al. Ultrasonographic assessment of cervical length and measurement of fetal fibronectin level in cervical secretion of pregnant women in prophylaxis of premature deliveries. Ginekol Pol. 2001;72(12):1139–1143. Polish.
   PubMedGoogle Scholar
• Fox N, Saltzman D, Klauser C, et al. Prediction of spontaneous preterm birth in asymptomatic triplet pregnancies using fetal fibronectin and cervical length [abstract]. Am J Obstet Gynecol. 2009;20:S171.
   Google Scholar
• Fox NS, Rebarber A, Roman AS, et al. The significance of a positive fetal fibronectin in the setting of a normal cervical length in twin pregnancies. Am J Perinatol. 2012;29(4):267–272.
   PubMed Web of Science ®Google Scholar
• Fox NS, Rebarber A, Roman AS, et al. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies. J Matern Fetal Neonatal Med. 2012;25(11):2308–2311.
   PubMed Web of Science ®Google Scholar
• Fox N, Bergh E, Oppal S, et al. The association between a short cervix, fetal fibronectin, and preterm birth in twin pregnancies, analyzed by cause of preterm birth: preterm labor, premature rupture of membranes, and indicated preterm birth [abstract]. Am J Obstet Gynecol. 2014;210(1 Suppl):S400.
   Web of Science ®Google Scholar
• Foxman EF, Jarolim P. Use of the fetal fibronectin test in decisions to admit to hospital for preterm labor. Clin Chem. 2004;50(3):663–665.
   PubMed Web of Science ®Google Scholar
• Fuchs F, Lefevre C, Sénat MV, et al. Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study. Sci Rep. 2018;8(1):2160.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang JP, Chen H, et al. Fetal fibronectin detection for preterm birth prediction. Genet Mol Res. 2014;13(1):1323–1328.
   PubMed Web of Science ®Google Scholar
• García Alonso A, Ayala Méndez JA, Izquierdo Puente JC, et al. Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor. Ginecol Obstet Mex. 1999;67:23–28. Spanish.
   Google Scholar
• García Alonso LA, Jiménez SG, Ayala Méndez JA, et al. Clinical usefulness of fetal fibronectin (fFn) expression in cervico-vaginal secretions (CVS). Ginecol Obstet Mex. 2002;70:379–384. Spanish.
   Google Scholar
• García Alonso LA, Ayala Méndez JA, Jiménez Solís G, et al. Economical impact of preterm delivery management based on fetal fibronectin results. Ginecol Obstet Mex. 2004;72:385–393. Spanish.
   Google Scholar
• Giles W, Bisits A, Knox M, et al. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol. 2000;182(2):439–442.
   PubMed Web of Science ®Google Scholar
• Goffeng AR, Holst E, Milsom I, et al. Fetal fibronectin and microorganisms in vaginal fluid of women with complicated pregnancies. Acta Obstet Gynecol Scand. 1997;76(6):521–527.
   PubMed Web of Science ®Google Scholar
• Goffinet F, Kayem G, Maillard F, et al. Detection of interleukin 6 mRNA by RT-PCR in vaginal secretions: association with preterm delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol. 2005;123(2):167–173.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Mercer BM, Meis PJ, et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 1996;87(5 Pt 1):643–648.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Mercer BM, Iams JD, et al. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1997;177(1):8–12.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Klebanoff M, Carey JC, et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks’ gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183(2):469–475.
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol. 2005;192:350–359. Erratum in: Gomez R, Romero R, Medina L, et al. Am J Obstet Gynecol. 2005;192:308–309.
   Google Scholar
• Gómez-Bravo Topete E, Castillo-Lechuga C, Villegas-Su A, et al. Valor predictivo de la fibronectina fetal en amenaza de parto pretérmino [Predictive value of fetal fibronectin for preterm labor]. Cir Cir. 2004;72(6):491–494 [Spanish].
   PubMedGoogle Scholar
• Gonzalez N, Bige V, Kandoussi S, et al. Mesure échographique de la longueur du col de l’utérus dans les grossesses gemellaires avec menace d’accouchement prématuré: comparaison avec les grossesses uniques [Ultrasonographic measurement of cervical length in twin pregnancies with preterm labor: comparison with singleton pregnancies]. Gynécol Obstet Fertil. 2004;32(2):122–127 [French].
   PubMedGoogle Scholar
• Grandi CA, Perego M, Briozzo G, et al. Fibronectina fetal (fFN) en secrecion cervical como predictor des parto prematuro [Fetal fibronectin in prediction of preterm or imminent delivery]. Rev Hosp Mat Inf Ramon Sarda. 1996;XV:127–136.
   Google Scholar
• Greenhagen JB, Van Wagoner J, Dudley D, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol. 1996;175(4 Pt 1):1054–1056.
   PubMed Web of Science ®Google Scholar
• Grenache DG, Hankins K, Parvin CA, et al. Cervicovaginal interleukin-6, tumor necrosis factor-a, and interleukin-2Rαs markers of preterm delivery. Clin Chem. 2004;50:1–3.
   Google Scholar
• Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol. 2004;191(1):235–240.
   PubMed Web of Science ®Google Scholar
• Groom KM, Liu E, Allenby K. The impact of fetal fibronectin testing for women with symptoms of preterm labor in routine clinical practice within a New Zealand population. Aust N Z J Obstet Gynaecol. 2006;46(5):440–445.
   PubMed Web of Science ®Google Scholar
• Hadži-Lega M, Markova AD, Stefanovic M, et al. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling. J Perinat Med. 2015;43(5):545–551.
   PubMed Web of Science ®Google Scholar
• Heath VC, Daskalakis G, Zagaliki A, et al. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG. 2000;107(10):1276–1281.
   PubMed Web of Science ®Google Scholar
• Hedriana HL, Bliss CB, Gilbert WM. Implementation of fetal fibronectin (FFN) testing in a large private practice hospital is safe and effective for the diagnosis and management of preterm labor (PTL) [abstract]. Am J Obstet Gynecol. 2005;193:S52.
   Google Scholar
• Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol. 1995;102(3):207–212.
   PubMedGoogle Scholar
• Henrich W. Cervicometry and fibronectin role. J Matern Fetal Neonatal Med. 2010;23(Suppl 1):39.
   Google Scholar
• Hezelgrave NL, Abbott DS, Radford SK, et al. Quantitative fetal fibronectin at 18 weeks of gestation to predict preterm birth in asymptomatic high-risk women. Obstet Gynecol. 2016;127(2):255–263.
   PubMed Web of Science ®Google Scholar
• Hincz P, Wilczynski J, Kozarzewski M, et al. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand. 2002;81(1):58–63.
   PubMed Web of Science ®Google Scholar
• Holmgren C, Lacoursière Y, Esplin S. Clinical predictors of a false negative fetal fibronectin (FFN) [abstract]. Am J Obstet Gynecol. 2007;197:S204.
   Google Scholar
• Hux CH, Trolice MP, Kadar N. The value of a single fetal fibronectin assay as a screen for preterm labor and delivery. J Matern Fetal Neonatal Med. 1995;4(3):100–104.
   Google Scholar
• Iams JD, Casal D, McGregor JA, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol. 1995;173(1):141–145.
   PubMed Web of Science ®Google Scholar
• Iams JD, Newman RB, Thom EA, et al., for the National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med. 2002;346(4):250–255.
   PubMed Web of Science ®Google Scholar
• Incerti M, Ghidini A, Korker V, et al. Performance of cervicovaginal fetal fibronectin in a community hospital setting. Arch Gynecol Obstet. 2007;275(5):347–351.
   PubMedGoogle Scholar
• Inglis SR, Jeremias J, Kuno K, et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol. 1994;171(1):5–10.
   PubMed Web of Science ®Google Scholar
• Irion O, Matute J, Bischof P. Prédiction de la prématurité par la fibronectin oncofoetale [Prediction of prematurity with oncofoetal fibronectin: a prospective cohort study]. J Gynecol Obstet Biol Reprod. 1995;24:624–629 [French].
   Google Scholar
• Iriye B, Hancock J, Wold S, et al. Fetal fibronectin (fFn) testing in symptomatic patients for preterm labor and McDonald cerclage [abstract]. Am J Obstet Gynecol. 2004;191:S111.
   Google Scholar
• Joffe GM, Jacques D, Bemis-Heys R, et al. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol. 1999;180(3 Pt 1):581–586.
   PubMed Web of Science ®Google Scholar
• Karunakaran B, Berry J, Parasuraman R. Can we raise the threshold for negative fetal fibronectin result? Arch Dis Child Fetal Neonat Ed. 2012;97(Suppl 1):A89.3–A8A89.
   Google Scholar
• Keeler SM, Roman AS, Coletta JM, et al. Fetal fibronectin testing in patients with short cervix in the midtrimester: can it identify optimal candidates for ultrasound-indicated cerclage? Am J Obstet Gynecol. 2009;200(2):158.e1–158.e6.
   Web of Science ®Google Scholar
• Khambay H, Bolt LA, Chandiramani M, et al. The Actim Partus test to predict pre-term birth in asymptomatic high-risk women. J Obstet Gynaecol. 2012;32(2):132–134.
   PubMedGoogle Scholar
• Kim RS, Gupta S, Lam-Rachlin J, et al. Fetal fibronectin, cervical length, and the risk of preterm birth in patients with an ultrasound or physical exam indicated cervical cerclage. J Matern Fetal Neonatal Med. 2016;29(22):3602–3605.
   PubMed Web of Science ®Google Scholar
• Krems J, McGregor J, Hastings C, et al. Fetal fibronectin in cervical secretions: an aid for predicting delivery in women at high risk for preterm delivery [abstract]. Am J Obstet Gynecol. 1995;172(1 Suppl):406S.
   Google Scholar
• Kuhrt K, Unwin C, Hezelgrave N, et al. Endocervical and high vaginal quantitative fetal fibronectin in predicting preterm birth. J Matern Fetal Neonatal Med. 2014;27(15):1576–1579.
   PubMed Web of Science ®Google Scholar
• Langer B, Boudier E, Schlaeder G. Prediction of preterm delivery by fetal fibronectin in an asymptomatic population [abstract]. Proceedings of the 15th European Congress of Perinatal Medicine; 10–13 Sept 1996, Glasgow, UK.
   Google Scholar
• Langer B, Boudier E, Schlaeder G. Cervico-vaginal fetal fibronectin: predictive value during false labor. Acta Obstet Gynecol Scand. 1997;76(3):218–221.
   PubMed Web of Science ®Google Scholar
• LaShay N, Gilson G, Joffe G, et al. Will cervicovaginal interleukin-6 combined with fetal fibronectin testing improve the prediction of preterm delivery? J Matern Fetal Med. 2000;9(6):336–341.
   PubMedGoogle Scholar
• Lee GT, Burwick R, Zork N, et al. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times? J Matern Fetal Neonatal Med. 2013;26(7):706–709.
   PubMed Web of Science ®Google Scholar
• Leeson SC, Maresh MJ, Martindale EA, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol. 1996;103(1):48–53.
   PubMedGoogle Scholar
• Lin M, Lee RM, Elliott JP. Fetal fibronectin as a predictor of preterm birth in quadruplet pregnancies [abstract]. Am J Obstet Gynecol. 2004;191:S111.
   Google Scholar
• Liong S, Di Quinzio MKW, Fleming G, et al. New biomarkers for the prediction of spontaneous preterm labor in symptomatic pregnant women: a comparison with fetal fibronectin. BJOG. 2015;122(3):370–379.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Wein R, Lapinski R, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol. 1993;169(4):798–804.
   PubMed Web of Science ®Google Scholar
• Lopez-Farfan JA, Sanchez Tovar HB, del Rayo Gutiérrez de Anda M, et al. Fibronectina fetal y longitud cervical como predictores tempranos de parto pretérmino [Fetal fibronectin and cervical length as early predictors of preterm labor]. Ginecol Obstet Mex. 2011;79:337–343 [Spanish].
   Google Scholar
• Lorenz-Eberhardt G, Weiss PAM, Haas J, et al. Frühgeburt und fetales fibronectin im Zervikal- und Vaginalsekret [Premature delivery and fetal fibronectin in the cervical and vaginal secretion]. Geburtsh Frauenheilk. 1994;54(7):414–416.
   PubMed Web of Science ®Google Scholar
• Lowe MP, Zimmerman B, Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol. 2004;190(2):358–362.
   PubMed Web of Science ®Google Scholar
• Luzzi V, Hankins K, Gronowski AM. Accuracy of the rapid fetal fibronectin TLi system in predicting preterm delivery. Clin Chem. 2003;49(3):501–502.
   PubMed Web of Science ®Google Scholar
• Magro-Malosso E, Seravalli V, Cozzolino M, et al. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤20 mm. J Matern Fetal Neonatal Med. 2017;30(3):294–297.
   PubMed Web of Science ®Google Scholar
• Maharajan P, Elliot J, Thampi P. Efficacy of fibronectin and its impact on the use of atosiban-cost implication. Arch Dis Child Fetal Neonat Ed. 2012;97(Suppl 1):A92.2–A9A92.
   Google Scholar
• Malak TM, Sizmur F, Bell SC, et al. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol. 1996;103(7):648–653.
   PubMedGoogle Scholar
• Mansouri A, Tadjerouni A, El Rabiey G, et al. La fibronectin foetale est-elle un bon test de l’accouchement prématuré? [Fibronectin: a predictor of preterm delivery?]. Contracept Fertil Sex. 1997;25(5):380–384 [French].
   PubMedGoogle Scholar
• Mateus J, Pereira L, Baxter J, et al. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions. Am J Perinatol. 2007;24(6):381–385.
   PubMed Web of Science ®Google Scholar
• Matthews KC, Gupta S, Lam-Rachlin J, et al. The association between fetal fibronectin and spontaneous preterm birth in twin pregnancies with a shortened cervical length. J Matern Fetal Neonatal Med. 2017;10:1–5.
   Google Scholar
• McKenna DS, Chung K, Iams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med. 1999;44(9):796–800.
   PubMed Web of Science ®Google Scholar
• McLaren JS, Hezelgrave NL, Ayubi H, et al. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse. Am J Obstet Gynecol. 2015;212(1):89.e1–89.e5.
   Web of Science ®Google Scholar
• McMahon KS, Neerhof MG, Haney EI, et al. Prematurity in multiple gestations: identification of patients who are at low risk. Am J Obstet Gynecol. 2002;186(6):1137–1141.
   PubMed Web of Science ®Google Scholar
• Melchor JC, Navas H, Marcos M, et al. Retrospective cohort study of PAMG-1 and fetal fibronectin test peformance in assessing spontaneous preterm birth risk in symptomatic women attending an emergency obstetrical unit. Ultrasound Obstet Gynecol. 2017.
   Google Scholar
• Morrison JC, Allbert JR, McLaughlin BN, et al. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol. 1993;168(2):538–542.
   PubMed Web of Science ®Google Scholar
• Morrison JC, Naef RW 3rd, Botti JJ, et al. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol. 1996;87(5 Pt 1):649–655.
   PubMed Web of Science ®Google Scholar
• Muzaffar S, Behrens R, Barns F, et al. Quantitative fetal fibronectin and preterm delivery. Br J Obstet Gynaecol. 2013;120(Suppl 1):595–596.
   Google Scholar
• Myint HH, Ciopec A, Roberts N, et al. Use of fetal fibronectin testing in a district general hospital in women with symptoms of preterm labour. Br J Obstet Gynaecol. 2013;120(Suppl1):41–49.
   Google Scholar
• Myint H, Singh V, Roberts NJ. Introducing fetal fibronectin testing to a District General Hospital in women with symptoms of preterm labour. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa83.
   Google Scholar
• Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol. 1994;170(1 Pt 1):20–25.
   PubMed Web of Science ®Google Scholar
• Ness A, Airoldi J, Modena A, et al. Triage of women with possible preterm labor using transvaginal ultrasound cervical length and fetal fibronectin [abstract]. Am J Obstet Gynecol. 2005;193:S58.
   Google Scholar
• Ness A, Visintine J, Ricci E, et al. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol. 2007;197(4):426.e1–426.e7.
   PubMed Web of Science ®Google Scholar
• Nikolova T, Bayev O, Nikolova N, et al. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015;43(4):395–402.
   PubMed Web of Science ®Google Scholar
• Northridge R, Liu H, Youssef R, et al. Predicting pre-term birth using fetal fibronectin (FFN) in Ninewells Hospital, Dundee. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa69.
   Google Scholar
• O’Brien JM, Mercer B, Pitts DW, et al. A comparison of fetal fibronectin, prolactin and cervical examination for the prediction of preterm delivery in symptomatic patients [abstract]. Am J Obstet Gynecol. 1995;172(1 Suppl):406S.
   Google Scholar
• Oliveira T, de Souza E, Mariani-Neto C, et al. Fetal fibronectin as a predictor of preterm delivery in twin gestations. Int J Gynecol Obstet. 1998;62(2):135–139.
   PubMed Web of Science ®Google Scholar
• Oliveira TA, Carvalho CM, de Souza E, et al. Detection of fetal fibronectin in twin pregnancies in relation to gestational age. Sao Paulo Med J. 1999;117(3):121–124.
   PubMedGoogle Scholar
• Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labor as a predictor of delivery before 34 weeks gestation. Aust N Z J Obstet Gynaecol. 1995;35(3):257–261.
   PubMed Web of Science ®Google Scholar
• Paternoster DM, Stella A, Gerace P, et al. Biochemical markers for the prediction of spontaneous pre-term birth. Int J Gynecol Obstet. 2002;79(2):123–129.
   PubMed Web of Science ®Google Scholar
• Patricot MC, Pallant-Delaroa A, Mathion B. Etude de la fibronectin comme marqueur de la menace d’accouchement prématuré [Fetal fibronectin for prediction of preterm delivery]. Immunoanal Biol Spéc. 1997;12:81–84 [French].
   Google Scholar
• Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177(1):13–18.
   PubMed Web of Science ®Google Scholar
• Peláez LM, Fox NS, Chasen ST. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help? J Perinat Med. 2008;36(3):202–205.
   PubMed Web of Science ®Google Scholar
• Pilpel S, Markenson G, Hoffman D. A comparison of fetal fibronectin testing in predicting preterm birth in twin verses singleton gestations [abstract]. Am J Obstet Gynecol. 2002;187:S120.
   Google Scholar
• Qirko R, Cipo M, Habibaj J, et al. Use of fibronectin predictor for preterm delivery in Albania. J Perinat Med. 2013;41(Suppl 1)1055.
   Google Scholar
• Ramirez M, Turrentine M. Comparison of fetal fibronectin and home uterine monitoring as predictors of preterm delivery in twin gestations [abstract]. Am J Obstet Gynecol. 1999;180:S104.
   Google Scholar
• Ray D, Dyson D, Permanente K. Fetal fibronectin as a predictor of preterm delivery in symptomatic patients [abstract]. Am J Obstet Gynecol. 2001;184:S37.
   Google Scholar
• Riboni F, Vitulo A, Dell’avanzo M, et al. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylmated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet. 2011;284(6):1325–1329.
   PubMed Web of Science ®Google Scholar
• Rinehart BK, Terrone DA, Isler CM, et al. Pregnancy outcome in women with preterm labor symptoms without cervical change. Am J Obstet Gynecol. 2001;184(5):1004–1007.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Arduini D, et al. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1996;175(5):1146–1151.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Vlachopoulou A, et al. The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor and intact membranes. J Perinat Med. 1997;25(6):461–468.
   PubMed Web of Science ®Google Scholar
• Roman AS, Rebarber A, Sfakianaki AK, et al. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in the patient with cervical cerclage. Am J Obstet Gynecol. 2003;189(5):1368–1373.
   PubMed Web of Science ®Google Scholar
• Roman AS, Koklanaris N, Paidas MJ, et al. ‘Blind’ vaginal fetal fibronectin as a predictor of spontaneous preterm delivery. Obstet Gynecol. 2005;105(2):285–289.
   PubMed Web of Science ®Google Scholar
• Roman A, Fox N, Rebarber A, et al. Positive fetal fibronectin in the setting of a normal cervical length in asymptomatic patients with twin pregnancies: what is the difference? [abstract]. Am J Obstet Gynecol. 2011;204:S206.
   Google Scholar
• Roman AS, Pessel C, Fox N, et al. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in triplet gestations. J Matern Fetal Neonatal Med. 2012;25(10):1921–1923.
   PubMed Web of Science ®Google Scholar
• Romero J, Rebarber A, Saltzman DH, et al. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length. Am J Obstet Gynecol. 2012;207(1):51.e1–51.e5.
   Web of Science ®Google Scholar
• Roos C, Vis JY, Scheepers HC, et al. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolyis. J Matern Fetal Neonatal Med. 2016;29(10):1556–1561.
   PubMed Web of Science ®Google Scholar
• Roubille M, Mailliavin A, Biguet-Vernier B, et al. Intérêt de la recherche de la fibronectin foetale dans le dépistage du risque d’accouchement prématuré [Fetal fibronectin as predictor of preterm birth]. Ann Biol Clin. 1999;57:93–97 [French].
   Google Scholar
• Rozenberg P, Nisand I, Malagrida L, et al. Utilisation rationnelle de la fibronectin foetale dans l’évaluation du risque d’accouchement prématuré [Rational use of fetal fibronectin in the evaluation of premature labor risk]. J Gynecol Obstet Biol Reprod. 1996;25:288–293 [French].
   Google Scholar
• Rozenberg P, Goffinet F, Malagrida L, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal sonographic measurement of cervical length. Am J Obstet Gynecol. 1997;176(1 Pt 1):196–199.
   PubMed Web of Science ®Google Scholar
• Ruiz RJ, Fullerton J, Brown CE. The utility of fFn for the prediction of preterm birth in twin gestations. J Obstet Gynecol Neonatal Nurs. 2004;33(4):446–454.
   PubMed Web of Science ®Google Scholar
• Sakai M, Sasaki Y, Yamagishi N, et al. The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes. Obstet Gynecol. 2003;101(1):123–128.
   PubMed Web of Science ®Google Scholar
• Schmitz T, Maillard F, Bessard-Bacquaert S, et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol. 2006;194(1):138–143.
   PubMed Web of Science ®Google Scholar
• Senden IPM, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labor. Clin Exp Obstet Gynecol. 1996;23(1):5–9.
   PubMedGoogle Scholar
• Shennan A, Jones G, Hawken J, et al. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG. 2005;112(3):293–298.
   PubMed Web of Science ®Google Scholar
• Shennan A, Crawshaw S, Briley A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006;113(1):65–74.
   PubMed Web of Science ®Google Scholar
• Singer E, Pilpel S, Bsat F, et al. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol. 2007;109(5):1083–1087.
   PubMed Web of Science ®Google Scholar
• Skoll A, St Louis P, Amiri N, et al.. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients. J Obstet Gynaecol Can. 2006;28(3):206–213.
   PubMedGoogle Scholar
• Smout EM, Seed PT, Shennan AH. The predictive value of fetal fibronectin testing in primiparous women with cervical surgery. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa129–FaFa130.
   Google Scholar
• Smout EM, Seed PT, Shennan AH. The use of fetal fibronectin in Primiparous women with cervical surgery. Arch Dis Child Fetal Neonat Ed. 2010;95(Suppl 1):Fa100.
   Google Scholar
• Smout E, Abbott D, Tezcan B, et al. The use of fetal fibronectin in women with rescue cervical cerclage. Arch Dis Child Fetal Neonat Ed. 2011;96(Suppl 1):Fa63–FaFa64.
   Google Scholar
• Stevens AO, Chauhan SP, Magann EF, et al. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor. Am J Obstet Gynecol. 2004;190:1582–7; discussion 1587. discussion:1587–1589.
   Google Scholar
• Sümer C, Yalvac S, Kandemir O, et al. Ultrasonografik servikal uzunluk ölçümü ve fetal fibronektin testinin gerçek preterm eylemi tespit etmedeki yeri. [The predictive value of sonographic cervical length measurement and fetal fibronectin testing to determine true preterm labor]. TJOD Derg. 2010;7:189–195 [Turkish].
   Google Scholar
• Sunagawa S, Takagi K, Ono K, et al. Comparison of biochemical markers and cervical length for predicting preterm delivery. J Obstet Gynaecol Res. 2008;34(5):812–819.
   PubMed Web of Science ®Google Scholar
• Surbek D, Bösiger H, Pavic N, et al. [Fetal fibronectin as a marker of prematurity in a high risk patient sample]. Z Geburtshilfe Neonatol. 1997;201(1):15–20.
   PubMed Web of Science ®Google Scholar
• Swamy GK, Simhan HN, Gammill HS, et al. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med. 2005;50(11):851–856.
   PubMed Web of Science ®Google Scholar
• Tekesin I, Marek S, Hellmeyer L, et al. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol. 2005;105(2):280–284.
   PubMed Web of Science ®Google Scholar
• Tekesin I, Eberhart LHJ, Schaefer V, et al. Evaluation and validation of a new risk score (Cleopatra score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol. 2005;26(7):699–706.
   PubMed Web of Science ®Google Scholar
• Terrone DA, Rinehart BK, Kraeden U, et al. Fetal fibronectin in symptomatic twin gestations. Prim Care Update Ob Gyns. 1998;5(4):179.
   PubMedGoogle Scholar
• Ting HS, Chin PS, Yeo GS, et al. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007;36(6):399–402.
   PubMed Web of Science ®Google Scholar
• Tolino A, Ronsini S, Zullo F, et al. Fetal fibronectin as a screening test for premature delivery in multiple pregnancies. Int J Gynecol Obstet. 1996;52(1):3–7.
   PubMed Web of Science ®Google Scholar
• Tripathi R, Tyagi S, Mala YM, et al. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth. Int J Gynecol Obstet. 2016;135(1):47–50.
   PubMed Web of Science ®Google Scholar
• Tsoi E, Akmal S, Geerts L, et al. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor. Ultrasound Obstet Gynecol. 2006;27(4):368–372.
   PubMed Web of Science ®Google Scholar
• van Baaren GJ, Vis JY, Wilms FF, et al. Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol. 2014;123(6):1185–1192.
   PubMed Web of Science ®Google Scholar
• Van Holsbeke C, Corremans A. Comparison of the fetal fibronectin (rapid FFN) and placental alpha microglobulin-1 (Partosure) tests for predicting imminent spontaneous preterm birth in patients with threatened preterm labor [abstract]. Proceedings of the 12th World Congress of Perinatal Medicine. 2015, Nov 3–6:O-0199.
   Google Scholar
• Vercoustre L, Sotter S, Bouige D, et al. Place de la fibronectin foetale dans la prédiction du travail. Résultats et commentaires à propos de 206 prélèvements [Fetal fibronectin as a predictor of labor (results and discussion about 206 samples)]. Ref Gynecol Obstet. 1996;4:23–32 [French].
   Google Scholar
• VÄtr M, Kudela M, Prásilová J. Fetal fibronectin in patients at increased risk for premature birth. Acta Univ Palacki Olomuc Fac Med. 1996;140:55–57.
   Google Scholar
• Vial Y, Irion O, Hohlfeld P, et al. Oncofetal fibronectin in prediction of preterm or imminent delivery [abstract]. Proceedings of the 14th European Congress of Perinatal Medicine; 5–8 Jun, 1994; Helsinki, Finland.
   Google Scholar
• Voluménie JL, Guibourdenche J, Doridot V, et al. Failure of cervical fibronectin to predict premature delivery in a population of monofetal pregnancies with idiopathic preterm labor. Eur J Obstet Gynecol Reprod Biol. 2001;97(1):35–39.
   PubMed Web of Science ®Google Scholar
• von Schöning D, Fischer T, von Tucher E, et al. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test. J Perinat Med. 2015;43(5):531–536.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang Z, Di H. The relationship between fetal fibronectin, bacteria vaginosis and chorioamnionitis. Zhonghua Fu Chan Ke Zhi. 1999;34(7):399–400 [Chinese].
   PubMedGoogle Scholar
• Wennerholm UB, Holm B, Mattsby-Baltzer I, et al. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol. 1997;104(12):1398–1404.
   PubMedGoogle Scholar
• Wilms FF, van Stralen G, Porath MM, et al. Voorspellen van dreigende vroeggeboorte door middel van bepaling van foetaal fibronectin in vaginaal vocht . [Predicating imminent preterm labor based on a determination of foetal fibronectin in a vaginal smear]. Ned Tijdschr Geneeskd. 2009;153:B398 [Dutch].
   Google Scholar
• Wing DA, Haeri S, Silber AC, et al. Placental alpha Microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017;130(6):1183–1191.
   PubMed Web of Science ®Google Scholar
• Yoneda S, Sakai M, Sasaki Y, et al. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes. J Obstet Gynaecol Res. 2007;33(1):38–44.
   PubMed Web of Science ®Google Scholar
• Zamora-Scorza FC, Fernandez G, De Lamanna MP, et al. Valor de la fibronectina fetal en secreciones cervicales en la prediccion del parto pretermino en pacientes con membranas integras. [Value of the fetal fibronectin in cervical secretions in the prediction of patients with the preterm labor with intact membranes]. Rev Obstet Ginecol Venez. 2000;60:15–22. Spanish.
   Google Scholar
• Zhou MX, Zhou J, Bao Y, et al. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors. J Matern Fetal Neonatal Med. 2015;28(2):153–157.
   PubMed Web of Science ®Google Scholar
• Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med. 1975;293(5):257.
   PubMed Web of Science ®Google Scholar
• Available from: https://itunes.apple.com/us/app/docnomo/id901279945?mt=8.
   Google Scholar
• Raju TNK. Epidemiology of late (near-term) preterm births. Clin Perinatol. 2006;33(4):751–63; abstract vii.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwilde estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
   PubMed Web of Science ®Google Scholar
• Colombo DF. Predicting spontaneous preterm birth. BMJ. 2002;325(7359):289–290.
   PubMed Web of Science ®Google Scholar